CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | tert-butyl hydroperoxide |
|
Accession: | CHEBI:64090
|
browse the term
|
Definition: | An alkyl hydroperoxide in which the alkyl group is tert-butyl. It is widely used in a variety of oxidation processes. |
Synonyms: | related_synonym: | 1,1-Dimethylethyl hydroperoxide; 2-Hydroperoxy-2-methylpropane; Dimethylethyl hydroperoxide; Formula=C4H10O2; Hydroperoxyde de butyle tertiaire; InChI=1S/C4H10O2/c1-4(2,3)6-5/h5H,1-3H3; InChIKey=CIHOLLKRGTVIJN-UHFFFAOYSA-N; SMILES=CC(C)(C)OO; TBHP; Tertiary-butyl hydroperoxide; t-Butylhydroperoxide; t-butyl hydroperoxide; tert-Butylhydroperoxide |
| xref: | Beilstein:1098280; CAS:75-91-2 |
| xref_mesh: | MESH:D020122 |
| xref: | PMID:21418283; PMID:22037478; PMID:22039964; PMID:22326806; PMID:22337620; PMID:22369679; Reaxys:1098280; Wikipedia:Tert-Butyl_hydroperoxide |
|
|
|
G |
4930563E22Rik |
RIKEN cDNA 4930563E22 gene |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of C17ORF100 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr11:72,105,964...72,109,276
Ensembl chr11:72,105,964...72,109,270
|
|
G |
9130401M01Rik |
RIKEN cDNA 9130401M01 gene |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of C8ORF76 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr15:57,885,666...57,897,690
Ensembl chr15:57,891,639...57,939,821 Ensembl chr15:57,891,639...57,939,821
|
|
G |
Abca1 |
ATP-binding cassette, sub-family A member 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ABCA1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
|
|
G |
Abcb11 |
ATP-binding cassette, sub-family B member 11 |
multiple interactions affects localization decreases expression |
ISO |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCB11 protein]; Bilirubin analog inhibits the reaction [tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCB11 protein]; Bucladesine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCB11 protein]; tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCB11 protein tert-Butylhydroperoxide results in decreased expression of ABCB11 mRNA |
CTD |
PMID:16452108 PMID:24306262 PMID:34767876 |
|
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ABCB1A mRNA |
CTD |
PMID:14729362 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
decreases expression multiple interactions affects localization |
ISO |
tert-Butylhydroperoxide results in decreased expression of ABCC2 mRNA Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCC2 protein]; Bilirubin analog inhibits the reaction [tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCC2 protein]; Go 6976 inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCC2 protein]; tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCC2 protein |
CTD |
PMID:22956110 PMID:24306262 PMID:34303734 |
|
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
G |
Abcd1 |
ATP-binding cassette, sub-family D member 1 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ABCD1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr X:72,760,203...72,782,140
Ensembl chr X:72,760,203...72,782,140
|
|
G |
Abhd17a |
abhydrolase domain containing 17A |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ABHD17A mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:80,419,483...80,426,199
Ensembl chr10:80,419,488...80,426,175
|
|
G |
Ablim1 |
actin-binding LIM protein 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ABLIM1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:57,021,165...57,303,776
Ensembl chr19:57,021,165...57,303,351
|
|
G |
Abr |
active BCR-related gene |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ABR mRNA |
CTD |
PMID:15003993 |
|
NCBI chr11:76,307,560...76,468,515
Ensembl chr11:76,307,560...76,514,384
|
|
G |
Acads |
acyl-Coenzyme A dehydrogenase, short chain |
increases expression decreases expression multiple interactions |
EXP ISO |
tert-Butylhydroperoxide results in increased expression of ACADS mRNA tert-Butylhydroperoxide results in decreased expression of ACADS mRNA acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of ACADS mRNA]; acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of ACADS mRNA]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein]; tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein |
CTD |
PMID:15003993 PMID:26989860 |
|
NCBI chr 5:115,248,358...115,257,405
Ensembl chr 5:115,248,358...115,257,405
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions increases expression increases secretion |
ISO |
Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of ACHE protein] tert-Butylhydroperoxide results in increased expression of ACHE mRNA alternative form |
CTD |
PMID:16903848 |
|
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ACKR3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:90,131,702...90,143,446
Ensembl chr 1:90,131,702...90,144,473
|
|
G |
Aco1 |
aconitase 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ACO1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:40,143,429...40,199,011
Ensembl chr 4:40,143,081...40,198,338
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ACOT1 mRNA |
CTD |
PMID:14729362 |
|
NCBI chr12:84,056,276...84,064,444
Ensembl chr12:84,056,264...84,065,145
|
|
G |
Acot7 |
acyl-CoA thioesterase 7 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ACOT7 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 4:152,258,872...152,356,312
Ensembl chr 4:152,262,591...152,356,312
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ACSL3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:78,635,600...78,685,462
Ensembl chr 1:78,635,542...78,685,460
|
|
G |
Actb |
actin, beta |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ACTB mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509
|
|
G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ACTG2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:83,489,891...83,513,233
Ensembl chr 6:83,489,887...83,513,247
|
|
G |
Actn1 |
actinin, alpha 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ACTN1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:80,214,316...80,307,165
Ensembl chr12:80,214,321...80,307,145
|
|
G |
Actr3 |
ARP3 actin-related protein 3 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ACTR3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:125,320,642...125,363,464
Ensembl chr 1:125,320,642...125,363,464
|
|
G |
Actr3b |
ARP3 actin-related protein 3B |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ACTR3B mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:25,964,960...26,055,686
Ensembl chr 5:25,964,995...26,055,686
|
|
G |
Acy3 |
aminoacylase 3 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ACY3 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr19:4,036,570...4,040,007
Ensembl chr19:4,036,570...4,040,007
|
|
G |
Acyp1 |
acylphosphatase 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ACYP1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:85,319,172...85,335,257
Ensembl chr12:85,319,172...85,335,212
|
|
G |
Adam19 |
ADAM metallopeptidase domain 19 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ADAM19 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:45,945,329...46,038,174
Ensembl chr11:45,946,819...46,038,170
|
|
G |
Adam8 |
a disintegrin and metallopeptidase domain 8 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ADAM8 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 7:139,558,845...139,573,016
Ensembl chr 7:139,558,845...139,572,475
|
|
G |
Adam9 |
ADAM metallopeptidase domain 9 |
multiple interactions increases expression affects expression |
ISO |
[rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADAM9 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA] tert-Butylhydroperoxide affects the expression of ADAM9 mRNA |
CTD |
PMID:20847119 PMID:23410634 |
|
NCBI chr 8:25,439,627...25,507,138
Ensembl chr 8:25,439,627...25,506,943
|
|
G |
Adar |
adenosine deaminase, RNA-specific |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ADAR mRNA |
CTD |
PMID:14729362 PMID:15003993 |
|
NCBI chr 3:89,622,321...89,660,756
Ensembl chr 3:89,622,329...89,660,753
|
|
G |
Adat1 |
adenosine deaminase, tRNA-specific 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ADAT1 mRNA |
CTD |
PMID:15963989 |
|
NCBI chr 8:112,685,552...112,718,938
Ensembl chr 8:112,693,540...112,718,934
|
|
G |
Adcy3 |
adenylate cyclase 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ADCY3 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr12:4,183,397...4,263,525
Ensembl chr12:4,183,103...4,263,525
|
|
G |
Adcy9 |
adenylate cyclase 9 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ADCY9 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr16:4,102,750...4,255,094
Ensembl chr16:4,105,393...4,238,362
|
|
G |
Add2 |
adducin 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ADD2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:86,005,663...86,101,391
Ensembl chr 6:86,005,663...86,101,391
|
|
G |
Add3 |
adducin 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ADD3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:53,128,874...53,235,518
Ensembl chr19:53,128,874...53,235,830
|
|
G |
Adgrg6 |
adhesion G protein-coupled receptor G6 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ADGRG6 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:14,278,327...14,421,467
Ensembl chr10:14,278,327...14,421,403
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ADH7 mRNA |
CTD |
PMID:14729362 PMID:15336504 |
|
NCBI chr 3:137,903,828...137,937,803
Ensembl chr 3:137,923,521...137,939,143
|
|
G |
Adipor2 |
adiponectin receptor 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ADIPOR2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665
|
|
G |
Adm |
adrenomedullin |
multiple interactions increases expression |
ISO EXP |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADM mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADM mRNA] |
CTD |
PMID:14729362 PMID:15003993 PMID:15336504 PMID:20847119 PMID:29432895 |
|
NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027
|
|
G |
Adora1 |
adenosine A1 receptor |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ADORA1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,963...134,163,169
|
|
G |
Adora2b |
adenosine A2b receptor |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ADORA2B mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:62,139,810...62,157,278
Ensembl chr11:62,139,810...62,157,279
|
|
G |
Agk |
acylglycerol kinase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of AGK mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:40,302,010...40,378,723
Ensembl chr 6:40,302,106...40,373,696
|
|
G |
Ago2 |
argonaute RISC catalytic subunit 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of AGO2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr15:72,967,693...73,056,777
Ensembl chr15:72,967,693...73,056,784
|
|
G |
Agpat1 |
1-acylglycerol-3-phosphate O-acyltransferase 1 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of AGPAT1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr17:34,823,164...34,832,392
Ensembl chr17:34,823,236...34,832,423
|
|
G |
Ahsa1 |
AHA1, activator of heat shock protein ATPase 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of AHSA1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:87,313,189...87,320,772
Ensembl chr12:87,313,253...87,320,772
|
|
G |
AI837181 |
expressed sequence AI837181 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of C11ORF68 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:5,475,172...5,477,345
Ensembl chr19:5,475,172...5,477,341
|
|
G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
multiple interactions increases expression |
ISO |
resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of AIFM1 protein] |
CTD |
PMID:25522270 |
|
NCBI chr X:47,563,821...47,602,440
Ensembl chr X:47,563,821...47,602,440
|
|
G |
Aip |
aryl-hydrocarbon receptor-interacting protein |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of AIP mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:4,163,756...4,177,233
Ensembl chr19:4,164,446...4,175,858
|
|
G |
Ajuba |
ajuba LIM protein |
multiple interactions decreases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of AJUBA mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr14:54,804,926...54,815,118
Ensembl chr14:54,804,929...54,815,015
|
|
G |
Ak2 |
adenylate kinase 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of AK2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:128,887,017...128,905,322
Ensembl chr 4:128,885,751...128,905,322
|
|
G |
Ak4 |
adenylate kinase 4 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of AK4 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 4:101,273,675...101,324,968
Ensembl chr 4:101,276,474...101,324,192
|
|
G |
Akap12 |
A kinase anchor protein 12 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of AKAP12 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr10:4,216,329...4,309,471
Ensembl chr10:4,216,380...4,309,470
|
|
G |
Akap9 |
A kinase anchor protein 9 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of AKAP9 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:3,977,410...4,130,204
Ensembl chr 5:3,978,054...4,131,310
|
|
G |
Akr1b10 |
aldo-keto reductase family 1, member B10 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of AKR1B10 mRNA |
CTD |
PMID:23410634 PMID:34767876 |
|
NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885
|
|
G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of AKR1B8 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 6:34,331,081...34,345,396
Ensembl chr 6:34,331,054...34,345,398
|
|
G |
Akr1c13 |
aldo-keto reductase family 1, member C13 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of AKR1C13 mRNA |
CTD |
PMID:14729362 |
|
NCBI chr13:4,241,167...4,255,601
Ensembl chr13:4,241,149...4,255,595
|
|
G |
Akr1c20 |
aldo-keto reductase family 1, member C20 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of AKR1C1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr13:4,536,855...4,573,353
Ensembl chr13:4,536,848...4,573,344
|
|
G |
Akr1c21 |
aldo-keto reductase family 1, member C21 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of AKR1C2 mRNA |
CTD |
PMID:12414654 PMID:15336504 PMID:23410634 |
|
NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions decreases phosphorylation |
ISO |
3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of AKT1 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA] |
CTD |
PMID:29128606 PMID:35690295 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Akt2 |
thymoma viral proto-oncogene 2 |
decreases expression increases methylation |
ISO |
tert-Butylhydroperoxide results in decreased expression of AKT2 mRNA tert-Butylhydroperoxide results in increased methylation of AKT2 gene |
CTD |
PMID:27509014 |
|
NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251
|
|
G |
Alad |
aminolevulinate, delta-, dehydratase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ALAD mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
|
|
G |
Alas1 |
aminolevulinic acid synthase 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ALAS1 protein |
CTD |
PMID:21659532 |
|
NCBI chr 9:106,110,654...106,125,153
Ensembl chr 9:106,110,654...106,125,853
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase family 1, subfamily A1 |
decreases expression affects expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ALDH1A1 mRNA tert-Butylhydroperoxide affects the expression of ALDH1A1 mRNA |
CTD |
PMID:15336504 PMID:23410634 |
|
NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase family 1, subfamily A3 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ALDH1A3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 7:66,040,640...66,077,225
Ensembl chr 7:66,040,638...66,077,265
|
|
G |
Aldh1a7 |
aldehyde dehydrogenase family 1, subfamily A7 |
decreases response to substance increases expression |
EXP |
ALDH1A7 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of ALDH1A7 mRNA |
CTD |
PMID:14729362 PMID:15003993 |
|
NCBI chr19:20,670,318...20,704,920
Ensembl chr19:20,670,317...20,704,926
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
increases expression decreases response to substance |
ISO EXP |
tert-Butylhydroperoxide results in increased expression of ALDH2 mRNA ALDH2 protein results in decreased susceptibility to tert-Butylhydroperoxide |
CTD |
PMID:14729362 PMID:15003993 PMID:15336504 |
|
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
|
|
G |
Aldh3a2 |
aldehyde dehydrogenase family 3, subfamily A2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ALDH3A2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:61,114,240...61,158,267
Ensembl chr11:61,114,243...61,158,290
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ALDH4A1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:139,348,404...139,377,002
Ensembl chr 4:139,350,177...139,377,001
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase family 6, subfamily A1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ALDH6A1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:84,477,491...84,497,798
Ensembl chr12:84,477,491...84,497,778
|
|
G |
Aldh7a1 |
aldehyde dehydrogenase family 7, member A1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ALDH7A1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr18:56,657,794...56,706,112
Ensembl chr18:56,642,759...56,706,023
|
|
G |
Aldoc |
aldolase C, fructose-bisphosphate |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ALDOA mRNA |
CTD |
PMID:15003993 |
|
NCBI chr11:78,213,899...78,218,607
Ensembl chr11:78,213,794...78,218,607
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ALOX5 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
|
|
G |
Amd1 |
S-adenosylmethionine decarboxylase 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of AMD1 mRNA |
CTD |
PMID:27509014 |
|
NCBI chr10:40,163,454...40,178,184
Ensembl chr10:40,163,454...40,178,184
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of AMIGO2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr15:97,141,955...97,145,168
Ensembl chr15:97,142,006...97,145,168
|
|
G |
Amotl2 |
angiomotin-like 2 |
multiple interactions decreases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of AMOTL2 mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr 9:102,594,290...102,610,616
Ensembl chr 9:102,593,871...102,610,617
|
|
G |
Ampd3 |
adenosine monophosphate deaminase 3 |
increases expression |
ISO EXP |
tert-Butylhydroperoxide results in increased expression of AMPD3 mRNA |
CTD |
PMID:15003993 PMID:15336504 |
|
NCBI chr 7:110,367,291...110,411,612
Ensembl chr 7:110,367,413...110,411,612
|
|
G |
Amph |
amphiphysin |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of AMPH mRNA |
CTD |
PMID:12419474 PMID:15336504 |
|
NCBI chr13:19,132,524...19,335,089
Ensembl chr13:19,132,375...19,335,091
|
|
G |
Anapc5 |
anaphase-promoting complex subunit 5 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ANAPC5 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:122,925,522...122,960,402
Ensembl chr 5:122,925,522...122,959,402
|
|
G |
Angptl2 |
angiopoietin-like 2 |
multiple interactions increases expression |
ISO EXP |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANGPTL2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANGPTL2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANGPTL2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANGPTL2 mRNA] |
CTD |
PMID:15003993 PMID:20847119 |
|
NCBI chr 2:33,105,963...33,137,737
Ensembl chr 2:33,106,081...33,137,729
|
|
G |
Angptl7 |
angiopoietin-like 7 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ANGPTL7 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:148,579,737...148,584,919
Ensembl chr 4:148,579,640...148,584,917
|
|
G |
Ankmy2 |
ankyrin repeat and MYND domain containing 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ANKMY2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:36,207,123...36,247,290
Ensembl chr12:36,207,113...36,247,290
|
|
G |
Ankra2 |
ankyrin repeat family A member 2 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of ANKRA2 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr13:98,399,584...98,411,262
Ensembl chr13:98,399,582...98,411,262
|
|
G |
Ankrd10 |
ankyrin repeat domain 10 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ANKRD10 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:11,661,581...11,694,617
Ensembl chr 8:11,661,583...11,685,757
|
|
G |
Ankrd2 |
ankyrin repeat domain 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ANKRD2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:42,024,358...42,033,550
Ensembl chr19:42,024,439...42,033,549
|
|
G |
Ankrd37 |
ankyrin repeat domain 37 |
multiple interactions increases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr 8:46,449,945...46,452,904
Ensembl chr 8:46,449,939...46,458,744
|
|
G |
Ankrd6 |
ankyrin repeat domain 6 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ANKRD6 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:32,804,027...32,950,884
Ensembl chr 4:32,804,035...32,950,841
|
|
G |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ANP32A mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:62,248,637...62,286,084
Ensembl chr 9:62,248,575...62,286,094
|
|
G |
Anpep |
alanyl aminopeptidase, membrane |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ANPEP mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 7:79,471,551...79,497,958
Ensembl chr 7:79,471,551...79,510,807
|
|
G |
Anxa4 |
annexin A4 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ANXA4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:86,713,822...86,770,616
Ensembl chr 6:86,713,822...86,770,566
|
|
G |
Anxa8 |
annexin A8 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ANXA8 mRNA |
CTD |
PMID:14729362 PMID:15003993 |
|
NCBI chr14:33,807,936...33,822,528
Ensembl chr14:33,807,938...33,822,528
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of AOX1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:58,068,963...58,145,569
Ensembl chr 1:58,069,090...58,145,572
|
|
G |
Ap3b1 |
adaptor-related protein complex 3, beta 1 subunit |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of AP3B1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr13:94,492,332...94,702,838
Ensembl chr13:94,495,468...94,702,825
|
|
G |
Ap3d1 |
adaptor-related protein complex 3, delta 1 subunit |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of AP3D1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:80,542,790...80,578,137
Ensembl chr10:80,542,790...80,578,098
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression multiple interactions |
ISO |
tert-Butylhydroperoxide results in increased expression of APAF1 protein Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of APAF1 protein] [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA] |
CTD |
PMID:15877105 PMID:17419000 PMID:35690295 |
|
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
Aplp2 |
amyloid beta precursor-like protein 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of APLP2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:31,060,853...31,123,144
Ensembl chr 9:31,060,853...31,123,111
|
|
G |
Apoa5 |
apolipoprotein A-V |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of APOA5 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 9:46,179,906...46,183,219
Ensembl chr 9:46,179,931...46,183,217
|
|
G |
Apoe |
apolipoprotein E |
increases expression affects localization |
ISO |
tert-Butylhydroperoxide results in increased expression of APOE mRNA tert-Butylhydroperoxide affects the localization of APOE protein |
CTD |
PMID:15336504 PMID:19720132 |
|
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
|
|
G |
Apold1 |
apolipoprotein L domain containing 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of APOLD1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:134,958,964...134,963,799
Ensembl chr 6:134,958,681...134,963,799
|
|
G |
App |
amyloid beta precursor protein |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of APP mRNA |
CTD |
PMID:12419474 |
|
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
|
|
G |
Appl1 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of APPL1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr14:26,640,943...26,692,567
Ensembl chr14:26,640,945...26,693,189
|
|
G |
Appl2 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of APPL2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:83,435,897...83,484,741
Ensembl chr10:83,435,897...83,484,602
|
|
G |
Aqp1 |
aquaporin 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of AQP1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:55,313,284...55,325,540
Ensembl chr 6:55,313,417...55,325,540
|
|
G |
Aqp4 |
aquaporin 4 |
multiple interactions |
ISO |
tert-Butylhydroperoxide results in increased expression of and affects the localization of AQP4 protein |
CTD |
PMID:20648640 |
|
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
|
|
G |
Aqr |
aquarius |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of AQR mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:113,931,642...114,005,788
Ensembl chr 2:113,931,651...114,017,505
|
|
G |
Areg |
amphiregulin |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of AREG mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291
|
|
G |
Arf6 |
ADP-ribosylation factor 6 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ARF6 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:69,418,924...69,422,754
Ensembl chr12:69,418,924...69,420,557
|
|
G |
Arg2 |
arginase type II |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of ARG2 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr12:79,177,562...79,203,075
Ensembl chr12:79,177,551...79,203,075
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ARHGDIA mRNA |
CTD |
PMID:12419474 |
|
NCBI chr11:120,468,925...120,472,450
Ensembl chr11:120,468,930...120,472,450
|
|
G |
Arhgef10 |
Rho guanine nucleotide exchange factor 10 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ARHGEF10 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:14,956,405...15,051,085
Ensembl chr 8:14,961,663...15,051,085
|
|
G |
Arhgef7 |
Rho guanine nucleotide exchange factor |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ARHGEF7 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:11,778,053...11,885,219
Ensembl chr 8:11,777,721...11,885,219
|
|
G |
Arid3a |
AT-rich interaction domain 3A |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of ARID3A mRNA |
CTD |
PMID:23410634 |
|
NCBI chr10:79,762,877...79,790,852
Ensembl chr10:79,762,877...79,790,852
|
|
G |
Arl6ip1 |
ADP-ribosylation factor-like 6 interacting protein 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ARL6IP1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 7:117,718,113...117,728,848
Ensembl chr 7:117,718,114...117,728,885
|
|
G |
Arl6ip5 |
ADP-ribosylation factor-like 6 interacting protein 5 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ARL6IP5 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:97,187,753...97,210,276
Ensembl chr 6:97,187,650...97,210,276
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA] |
CTD |
PMID:35690295 |
|
NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551
|
|
G |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ARPC1A mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:145,020,679...145,045,566
Ensembl chr 5:145,020,640...145,045,571
|
|
G |
Asf1a |
anti-silencing function 1A histone chaperone |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ASF1A mRNA |
CTD |
PMID:23410634 |
|
NCBI chr10:53,473,057...53,485,321
Ensembl chr10:53,472,853...53,485,321
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ASF1B mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:84,682,323...84,696,824
Ensembl chr 8:84,682,136...84,696,826
|
|
G |
Asph |
aspartate-beta-hydroxylase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ASPH mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:9,449,085...9,669,344
Ensembl chr 4:9,448,069...9,669,344
|
|
G |
Aspscr1 |
ASPSCR1 tether for SLC2A4, UBX domain containing |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ASPSCR1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:120,563,878...120,600,273
Ensembl chr11:120,563,799...120,600,273
|
|
G |
Ass1 |
argininosuccinate synthetase 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ASS1 mRNA; tert-Butylhydroperoxide results in decreased expression of ASS1 protein |
CTD |
PMID:15336504 PMID:24394546 |
|
NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
|
|
G |
Asxl1 |
ASXL transcriptional regulator 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ASXL1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:153,187,750...153,245,927
Ensembl chr 2:153,187,749...153,245,927
|
|
G |
Atad2 |
ATPase family, AAA domain containing 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ATAD2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr15:57,957,440...57,998,516
Ensembl chr15:57,957,440...57,998,478
|
|
G |
Atf3 |
activating transcription factor 3 |
multiple interactions increases expression decreases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ATF3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ATF3 mRNA] tert-Butylhydroperoxide results in decreased expression of ATF3 mRNA |
CTD |
PMID:12414654 PMID:20196124 PMID:20847119 |
|
NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
|
|
G |
Atg4b |
autophagy related 4B, cysteine peptidase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ATG4B mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:93,682,627...93,717,328
Ensembl chr 1:93,679,222...93,718,332
|
|
G |
Atg5 |
autophagy related 5 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ATG5 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287
|
|
G |
Atp13a3 |
ATPase type 13A3 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ATP13A3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr16:30,131,241...30,207,674
Ensembl chr16:30,131,241...30,224,793
|
|
G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ATP2A2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:122,591,576...122,640,288
Ensembl chr 5:122,591,576...122,640,288
|
|
G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ATP2B1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:98,750,243...98,862,005
Ensembl chr10:98,750,268...98,862,005
|
|
G |
Atp6v1a |
ATPase, H+ transporting, lysosomal V1 subunit A |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ATP6V1A mRNA |
CTD |
PMID:15336504 |
|
NCBI chr16:43,905,765...43,960,055
Ensembl chr16:43,905,765...43,960,068
|
|
G |
Atp6v1c1 |
ATPase, H+ transporting, lysosomal V1 subunit C1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ATP6V1C1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr15:38,662,096...38,692,688
Ensembl chr15:38,662,177...38,692,690
|
|
G |
Atr |
ataxia telangiectasia and Rad3 related |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ATR mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 9:95,739,655...95,834,813
Ensembl chr 9:95,739,650...95,833,834
|
|
G |
Atxn1 |
ataxin 1 |
affects localization multiple interactions decreases expression |
ISO |
tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form]; Buthionine Sulfoximine promotes the reaction [tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form] tert-Butylhydroperoxide results in decreased expression of ATXN1 mRNA |
CTD |
PMID:12893416 PMID:15336504 |
|
NCBI chr13:45,703,231...46,118,467
Ensembl chr13:45,703,231...46,118,484
|
|
G |
Atxn3 |
ataxin 3 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ATXN3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:101,885,160...101,928,139
Ensembl chr12:101,885,160...101,924,505
|
|
G |
Aurka |
aurora kinase A |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of AURKA mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 2:172,198,116...172,212,825
Ensembl chr 2:172,198,110...172,212,455
|
|
G |
Aurkb |
aurora kinase B |
decreases expression increases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of AURKB mRNA tert-Butylhydroperoxide results in increased expression of AURKB mRNA |
CTD |
PMID:12414654 PMID:29432895 |
|
NCBI chr11:68,936,477...68,942,490
Ensembl chr11:68,936,473...68,942,490
|
|
G |
Auts2 |
autism susceptibility candidate 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of AUTS2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:131,466,171...132,572,059
Ensembl chr 5:131,466,171...132,572,183
|
|
G |
Azin1 |
antizyme inhibitor 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of AZIN1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr15:38,487,674...38,523,506
Ensembl chr15:38,487,671...38,519,510
|
|
G |
Babam1 |
BRISC and BRCA1 A complex member 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BABAM1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:71,848,809...71,857,416
Ensembl chr 8:71,849,505...71,857,263
|
|
G |
Babam2 |
BRISC and BRCA1 A complex member 2 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of BABAM2 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 5:31,855,394...32,242,083
Ensembl chr 5:31,855,028...32,242,306
|
|
G |
Bace2 |
beta-site APP-cleaving enzyme 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BACE2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr16:97,157,928...97,244,136
Ensembl chr16:97,157,942...97,244,136
|
|
G |
Bad |
BCL2-associated agonist of cell death |
decreases expression increases expression multiple interactions |
ISO |
tert-Butylhydroperoxide results in decreased expression of BAD mRNA tert-Butylhydroperoxide results in increased expression of BAD protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAD protein] |
CTD |
PMID:12419474 PMID:15569404 PMID:17419000 |
|
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BAK1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
decreases expression affects expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BAMBI mRNA tert-Butylhydroperoxide affects the expression of BAMBI mRNA |
CTD |
PMID:15336504 PMID:23410634 |
|
NCBI chr18:3,507,011...3,516,404
Ensembl chr18:3,507,923...3,516,404
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions decreases expression increases expression affects localization |
ISO EXP |
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of BAX protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; Peptides inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein] tert-Butylhydroperoxide results in decreased expression of BAX mRNA acadesine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein] |
CTD |
PMID:12419474 PMID:15569404 PMID:17419000 PMID:18552516 PMID:20510348 PMID:23994092 PMID:25522270 PMID:26989860 PMID:28063877 PMID:29111459 PMID:35690295 More...
|
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BAZ1B mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:135,214,094...135,274,985
Ensembl chr 5:135,216,118...135,274,983
|
|
G |
Bbln |
bublin coiled coil protein |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BBLN mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:32,269,120...32,271,877
Ensembl chr 2:32,267,109...32,271,950
|
|
G |
BC005537 |
cDNA sequence BC005537 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of C6ORF62 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr13:24,985,640...24,996,882
Ensembl chr13:24,985,640...25,000,180
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions decreases expression affects localization |
ISO EXP |
acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] tert-Butylhydroperoxide results in decreased expression of BCL2 mRNA; tert-Butylhydroperoxide results in decreased expression of BCL2 protein 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA; Genistein inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA]; Peptides inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] |
CTD |
PMID:12782109 PMID:15288519 PMID:15569404 PMID:17419000 PMID:19772912 PMID:20510348 PMID:22659508 PMID:23994092 PMID:25522270 PMID:26989860 PMID:27050144 PMID:29111459 PMID:29128606 PMID:35690295 More...
|
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
multiple interactions decreases expression |
ISO |
Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein]; puag-haad inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] tert-Butylhydroperoxide results in decreased expression of BCL2L1 mRNA; tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein |
CTD |
PMID:12419474 PMID:15569404 PMID:26102008 PMID:27050144 |
|
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Bcl2l13 |
BCL2 like 13 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BCL2L13 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:120,813,167...120,869,803
Ensembl chr 6:120,813,173...120,869,803
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase, type 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BDH1 mRNA |
CTD |
PMID:29432895 |
|
NCBI chr16:31,241,115...31,277,719
Ensembl chr16:31,241,098...31,277,719
|
|
G |
Bdnf |
brain derived neurotrophic factor |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of BDNF mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
|
|
G |
Bex2 |
brain expressed X-linked 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of BEX1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr X:134,967,314...134,968,985
Ensembl chr X:134,967,313...134,968,985
|
|
G |
Bex4 |
brain expressed X-linked 4 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of BEX4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr X:135,039,745...135,041,192
Ensembl chr X:135,039,745...135,041,192
|
|
G |
Bhmt |
betaine-homocysteine methyltransferase |
increases methylation decreases expression |
ISO |
tert-Butylhydroperoxide results in increased methylation of BHMT gene tert-Butylhydroperoxide results in decreased expression of BHMT mRNA |
CTD |
PMID:27509014 |
|
NCBI chr13:93,753,399...93,774,266
Ensembl chr13:93,753,183...93,774,469
|
|
G |
Bicd1 |
BICD cargo adaptor 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BICD1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:149,310,322...149,464,827
Ensembl chr 6:149,310,384...149,464,827
|
|
G |
Bik |
BCL2-interacting killer |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of BIK mRNA |
CTD |
PMID:23410634 |
|
NCBI chr15:83,410,992...83,428,836
Ensembl chr15:83,411,063...83,428,835
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of BIRC5 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
|
|
G |
Blnk |
B cell linker |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of BLNK mRNA |
CTD |
PMID:14729362 |
|
NCBI chr19:40,917,371...40,982,664
Ensembl chr19:40,917,371...40,982,978
|
|
G |
Bmal2 |
basic helix-loop-helix ARNT like 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BMAL2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:146,696,230...146,735,027
Ensembl chr 6:146,697,553...146,735,027
|
|
G |
Bmerb1 |
bMERB domain containing 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BMERB1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr16:13,802,975...13,922,916
Ensembl chr16:13,804,468...13,919,364
|
|
G |
Bmp1 |
bone morphogenetic protein 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BMP1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr14:70,711,998...70,758,280
Ensembl chr14:70,711,998...70,757,674
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BMP4 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr14:46,620,982...46,628,126
Ensembl chr14:46,620,977...46,628,126
|
|
G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
decreases expression increases expression |
ISO EXP |
tert-Butylhydroperoxide results in decreased expression of BNIP3 mRNA tert-Butylhydroperoxide results in increased expression of BNIP3 mRNA |
CTD |
PMID:12419474 PMID:15003993 |
|
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
|
|
G |
Bora |
bora, aurora kinase A activator |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BORA mRNA |
CTD |
PMID:15336504 |
|
NCBI chr14:99,283,880...99,311,976
Ensembl chr14:99,283,658...99,311,976
|
|
G |
Braf |
Braf transforming gene |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BRAF mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397
|
|
G |
Brd3 |
bromodomain containing 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BRD3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:27,335,588...27,397,669
Ensembl chr 2:27,335,591...27,397,674
|
|
G |
Brd3os |
bromodomain containing 3, opposite strand |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BRD3OS mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:27,332,486...27,334,233
Ensembl chr 2:27,332,336...27,334,233
|
|
G |
Bscl2 |
BSCL2 lipid droplet biogenesis associated, seipin |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of BSCL2 mRNA |
CTD |
PMID:22003191 |
|
NCBI chr19:8,814,831...8,826,047
Ensembl chr19:8,814,831...8,826,047 Ensembl chr 2:8,814,831...8,826,047
|
|
G |
Bst1 |
bone marrow stromal cell antigen 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BST1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:43,976,235...44,000,810
Ensembl chr 5:43,976,227...44,001,328
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BST2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:71,986,899...71,990,116
Ensembl chr 8:71,986,899...71,990,100
|
|
G |
Btbd2 |
BTB domain containing 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BTBD2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:80,478,457...80,492,328
Ensembl chr10:80,478,451...80,492,328
|
|
G |
Btd |
biotinidase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BTD mRNA |
CTD |
PMID:15336504 |
|
NCBI chr14:31,363,014...31,390,154
Ensembl chr14:31,362,985...31,390,536
|
|
G |
Btf3 |
basic transcription factor 3 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of BTF3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr13:98,446,405...98,453,514
Ensembl chr13:98,446,404...98,453,514
|
|
G |
Btg1 |
BTG anti-proliferation factor 1 |
decreases expression |
EXP |
tert-Butylhydroperoxide results in decreased expression of BTG1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr10:96,452,863...96,458,675
Ensembl chr10:96,452,868...96,458,671
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO EXP |
tert-Butylhydroperoxide results in increased expression of BTG2 mRNA |
CTD |
PMID:12414654 PMID:21382384 |
|
NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858
|
|
G |
Bub1 |
BUB1, mitotic checkpoint serine/threonine kinase |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of BUB1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 2:127,642,117...127,673,790
Ensembl chr 2:127,643,036...127,673,785
|
|
G |
Bud23 |
BUD23, rRNA methyltransferase and ribosome maturation factor |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of BUD23 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:135,081,811...135,093,813
Ensembl chr 5:135,081,811...135,093,813
|
|
G |
Bzw1 |
basic leucine zipper and W2 domains 1 |
multiple interactions increases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of BZW1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of BZW1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr 1:58,432,057...58,446,513
Ensembl chr 1:58,432,057...58,446,512
|
|
G |
C130074G19Rik |
RIKEN cDNA C130074G19 gene |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of C1ORF115 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:184,604,123...184,615,233
Ensembl chr 1:184,604,123...184,615,415
|
|
G |
C1rb |
complement component 1, r subcomponent B |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of C1R mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:124,547,389...124,558,003
Ensembl chr 6:124,547,253...124,558,130
|
|
G |
C2cd2 |
C2 calcium-dependent domain containing 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of C2CD2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr16:97,656,409...97,727,248
Ensembl chr16:97,656,409...97,763,798
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CADM1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:47,441,468...47,773,578
Ensembl chr 9:47,441,471...47,769,413
|
|
G |
Cadm4 |
cell adhesion molecule 4 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CADM4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 7:24,181,448...24,203,958
Ensembl chr 7:24,181,448...24,203,964
|
|
G |
Calhm2 |
calcium homeostasis modulator family member 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CALHM2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:47,120,671...47,126,733
Ensembl chr19:47,093,792...47,126,733
|
|
G |
Calm1 |
calmodulin 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CALM1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:100,165,694...100,176,083
Ensembl chr12:100,165,694...100,176,073
|
|
G |
Calm3 |
calmodulin 3 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CALM3 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 7:16,649,304...16,657,957
Ensembl chr 7:16,649,304...16,658,039
|
|
G |
Calml4 |
calmodulin-like 4 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CALML4 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 9:62,765,068...62,783,203
Ensembl chr 9:62,765,362...62,783,203
|
|
G |
Calr |
calreticulin |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CALR mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
|
|
G |
Calu |
calumenin |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CALU mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:29,348,105...29,376,674
Ensembl chr 6:29,348,068...29,377,109
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CAMK2N1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434
|
|
G |
Caml |
calcium modulating ligand |
decreases expression |
EXP |
tert-Butylhydroperoxide results in decreased expression of CAML mRNA |
CTD |
PMID:14729362 |
|
NCBI chr13:55,770,818...55,780,229
Ensembl chr13:55,770,818...55,780,224
|
|
G |
Camp |
cathelicidin antimicrobial peptide |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CAMP mRNA |
CTD |
PMID:22659508 |
|
NCBI chr 9:109,676,445...109,678,524
Ensembl chr 9:109,676,447...109,678,685
|
|
G |
Cand1 |
cullin associated and neddylation disassociated 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CAND1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:119,034,717...119,075,960
Ensembl chr10:119,035,160...119,075,960
|
|
G |
Capn1 |
calpain 1 |
increases response to substance increases expression |
ISO EXP |
CAPN1 protein results in increased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of CAPN1 mRNA |
CTD |
PMID:12842444 PMID:15003993 |
|
NCBI chr19:6,038,573...6,065,855
Ensembl chr19:6,038,573...6,065,927
|
|
G |
Capn2 |
calpain 2 |
decreases expression affects expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CAPN2 mRNA tert-Butylhydroperoxide affects the expression of CAPN2 mRNA |
CTD |
PMID:12419474 PMID:23410634 |
|
NCBI chr 1:182,294,818...182,345,175
Ensembl chr 1:182,294,825...182,345,173
|
|
G |
Capn5 |
calpain 5 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CAPN5 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 7:97,770,766...97,828,148
Ensembl chr 7:97,770,766...97,827,481
|
|
G |
Capn7 |
calpain 7 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CAPN7 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr14:31,058,582...31,093,944
Ensembl chr14:31,058,595...31,093,943
|
|
G |
Capns1 |
calpain, small subunit 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CAPNS1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 7:29,886,359...29,898,308
Ensembl chr 7:29,886,361...29,898,236
|
|
G |
Caprin2 |
caprin family member 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CAPRIN2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:148,743,990...148,797,756
Ensembl chr 6:148,743,990...148,797,735
|
|
G |
Car8 |
carbonic anhydrase 8 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CA8 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:8,141,491...8,239,226
Ensembl chr 4:8,143,362...8,239,041
|
|
G |
Cars2 |
cysteinyl-tRNA synthetase 2, mitochondrial |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CARS2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:11,564,017...11,600,781
Ensembl chr 8:11,563,977...11,600,783
|
|
G |
Cask |
calcium/calmodulin dependent serine protein kinase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CASK mRNA |
CTD |
PMID:12419474 |
|
NCBI chr X:13,383,319...13,713,020
Ensembl chr X:13,383,319...13,717,606
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases expression increases cleavage decreases expression decreases activity |
ISO EXP |
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA; acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CASP3 protein]; GPX4 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; KN 93 inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; MCL1 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; nectandrin-B inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; PAFAH2 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; puag-haad inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CASP3 protein]; rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; zinc protoporphyrin inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]] tert-Butylhydroperoxide results in increased expression of CASP3 protein; tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form 6,7-dihydroxyflavone inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; caffeoylquinic acid analog inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; tert-Butylhydroperoxide results in increased expression of and results in increased cleavage of CASP3 protein acadesine inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] tert-butylhydroperoxide decreases activity of Casp3 protein in hepatocyte cytosol |
CTD RGD |
PMID:12406338 PMID:15496407 PMID:15569404 PMID:15611089 PMID:15877105 PMID:16753784 PMID:17419000 PMID:19647727 PMID:19772912 PMID:20510348 PMID:20847119 PMID:26102008 PMID:26989860 PMID:27511913 PMID:28025122 PMID:28063877 PMID:28733231 PMID:35690295 PMID:38053484 PMID:18316105 More...
|
RGD:2311460 |
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp6 |
caspase 6 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CASP6 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752
|
|
G |
Casp7 |
caspase 7 |
multiple interactions increases cleavage decreases activity |
ISO |
Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP7 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP7 protein] tert-butylhydroperoxide decreases activity of Casp7 protein in hepatocyte cytosol |
CTD RGD |
PMID:27050144 PMID:18316105 |
RGD:2311460 |
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA] |
CTD |
PMID:35690295 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
increases cleavage increases expression multiple interactions decreases activity |
ISO EXP |
tert-Butylhydroperoxide results in increased cleavage of CASP9 protein tert-Butylhydroperoxide results in increased expression of CASP9 protein Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein] Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein] Tert-butylhydroperoxide decreases activity of Casp9 protein in hepatocyte cytosol |
CTD RGD |
PMID:15877105 PMID:17003459 PMID:19772912 PMID:20510348 PMID:27050144 PMID:18316105 More...
|
RGD:2311460 |
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cast |
calpastatin |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CAST mRNA |
CTD |
PMID:15336504 |
|
NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929
|
|
G |
Cat |
catalase |
affects response to substance decreases response to substance multiple interactions decreases activity decreases expression increases expression increases activity |
ISO EXP |
CAT protein affects the susceptibility to tert-Butylhydroperoxide CAT protein results in decreased susceptibility to tert-Butylhydroperoxide [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CAT mRNA; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CAT protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CAT protein] tert-Butylhydroperoxide results in decreased activity of CAT protein tert-Butylhydroperoxide results in decreased expression of CAT mRNA; tert-Butylhydroperoxide results in decreased expression of CAT protein CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of CAT protein] tert-Butylhydroperoxide results in increased expression of CAT mRNA CAT protein results in increased susceptibility to [tert-Butylhydroperoxide co-treated with Desoxycorticosterone co-treated with tempol] |
CTD |
PMID:10754530 PMID:11178967 PMID:12423650 PMID:12628296 PMID:12646410 PMID:14729362 PMID:15003993 PMID:15105052 PMID:15207383 PMID:15336504 PMID:15849717 PMID:16126241 PMID:16753784 PMID:16928893 PMID:17003459 PMID:20100471 PMID:34303734 PMID:35690295 More...
|
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Cav1 |
caveolin 1, caveolae protein |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CAV1 mRNA |
CTD |
PMID:15963989 |
|
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
|
|
G |
Cav2 |
caveolin 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CAV2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:17,281,184...17,289,129
Ensembl chr 6:17,281,184...17,289,114
|
|
G |
Cavin2 |
caveolae associated 2 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of CAVIN2 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 1:51,328,285...51,342,119
Ensembl chr 1:51,328,285...51,342,119
|
|
G |
Cbfb |
core binding factor beta |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CBFB mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:105,897,306...105,944,621
Ensembl chr 8:105,897,306...105,944,621
|
|
G |
Cbr3 |
carbonyl reductase 3 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CBR3 mRNA |
CTD |
PMID:21382384 |
|
NCBI chr16:93,480,107...93,487,879
Ensembl chr16:93,480,103...93,487,878
|
|
G |
Cbs |
cystathionine beta-synthase |
decreases expression increases methylation |
ISO |
tert-Butylhydroperoxide results in decreased expression of CBS mRNA tert-Butylhydroperoxide results in increased methylation of CBS gene |
CTD |
PMID:15336504 PMID:27509014 |
|
NCBI chr17:31,831,602...31,856,170
Ensembl chr17:31,827,868...31,856,212
|
|
G |
Ccdc25 |
coiled-coil domain containing 25 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CCDC25 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr14:66,074,751...66,104,053
Ensembl chr14:66,074,751...66,104,056
|
|
G |
Ccdc86 |
coiled-coil domain containing 86 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CCDC86 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:10,918,845...10,926,630
Ensembl chr19:10,918,845...10,926,630
|
|
G |
Ccdc93 |
coiled-coil domain containing 93 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CCDC93 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:121,358,796...121,434,189
Ensembl chr 1:121,358,778...121,434,189
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCL2 mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CCL5 mRNA |
CTD |
PMID:14729362 PMID:15003993 |
|
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CCN1 mRNA |
CTD |
PMID:12414654 PMID:15336504 |
|
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
|
|
G |
Ccn2 |
cellular communication network factor 2 |
multiple interactions decreases expression affects expression |
ISO |
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCN2 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCN2 mRNA] tert-Butylhydroperoxide affects the expression of CCN2 mRNA |
CTD |
PMID:20847119 PMID:23410634 |
|
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
|
|
G |
Ccn3 |
cellular communication network factor 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CCN3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr15:54,609,306...54,617,158
Ensembl chr15:54,609,098...54,617,435
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression affects expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CCNA2 mRNA tert-Butylhydroperoxide affects the expression of CCNA2 mRNA |
CTD |
PMID:12414654 PMID:12419474 PMID:15336504 PMID:23410634 |
|
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
|
|
G |
Ccnb2 |
cyclin B2 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CCNB2 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 9:70,314,971...70,328,836
Ensembl chr 9:70,314,974...70,328,829
|
|
G |
Ccne1 |
cyclin E1 |
multiple interactions |
ISO |
ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CCNE1 protein] |
CTD |
PMID:15606011 |
|
NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959
|
|
G |
Ccne2 |
cyclin E2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CCNE2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779
|
|
G |
Ccnf |
cyclin F |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CCNF mRNA |
CTD |
PMID:15003993 |
|
NCBI chr17:24,441,518...24,470,333
Ensembl chr17:24,441,172...24,470,458
|
|
G |
Ccng2 |
cyclin G2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CCNG2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:93,415,432...93,424,090
Ensembl chr 5:93,415,116...93,424,090
|
|
G |
Ccnj |
cyclin J |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CCNJ mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:40,819,345...40,837,016
Ensembl chr19:40,819,723...40,837,016
|
|
G |
Ccnk |
cyclin K |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CCNK mRNA |
CTD |
PMID:12419474 |
|
NCBI chr12:108,145,543...108,170,252
Ensembl chr12:108,145,838...108,169,618
|
|
G |
Ccs |
copper chaperone for superoxide dismutase |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CCS mRNA |
CTD |
PMID:14729362 PMID:15336504 |
|
NCBI chr19:4,875,394...4,889,326
Ensembl chr19:4,875,394...4,889,360
|
|
G |
Cd24a |
CD24a antigen |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CD24 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:43,454,433...43,460,261
Ensembl chr10:43,454,280...43,460,261
|
|
G |
Cd320 |
CD320 antigen |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CD320 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:34,062,065...34,068,748
Ensembl chr17:34,062,065...34,068,748
|
|
G |
Cd46 |
CD46 antigen, complement regulatory protein |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CD46 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:194,721,279...194,781,149
Ensembl chr 1:194,719,134...194,774,557
|
|
G |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CD47 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr16:49,671,691...49,732,799
Ensembl chr16:49,620,896...49,735,373
|
|
G |
Cd55 |
CD55 molecule, decay accelerating factor for complement |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CD55 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:130,357,526...130,390,513
Ensembl chr 1:130,366,764...130,390,481
|
|
G |
Cd68 |
CD68 antigen |
increases expression decreases response to substance |
ISO EXP |
tert-Butylhydroperoxide results in increased expression of CD68 mRNA CD68 protein results in decreased susceptibility to tert-Butylhydroperoxide |
CTD |
PMID:14729362 PMID:15003993 PMID:15336504 |
|
NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979
|
|
G |
Cd82 |
CD82 antigen |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CD82 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:93,249,447...93,293,295
Ensembl chr 2:93,249,456...93,293,485
|
|
G |
Cd9 |
CD9 antigen |
decreases expression affects expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CD9 mRNA tert-Butylhydroperoxide affects the expression of CD9 mRNA |
CTD |
PMID:15336504 PMID:23410634 |
|
NCBI chr 6:125,437,229...125,471,723
Ensembl chr 6:125,437,229...125,471,754
|
|
G |
Cd99 |
CD99 antigen |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CD99 mRNA |
CTD |
PMID:15336504 |
|
|
|
G |
Cdc16 |
CDC16 cell division cycle 16 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CDC16 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:13,807,650...13,831,951
Ensembl chr 8:13,807,676...13,831,938
|
|
G |
Cdc25b |
cell division cycle 25B |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CDC25B mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:131,028,356...131,040,431
Ensembl chr 2:131,028,869...131,040,417
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression increases expression |
ISO EXP |
tert-Butylhydroperoxide results in decreased expression of CDC25C mRNA tert-Butylhydroperoxide results in increased expression of CDC25C mRNA |
CTD |
PMID:12419474 PMID:14729362 PMID:15003993 |
|
NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586
|
|
G |
Cdc27 |
cell division cycle 27 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CDC27 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:104,393,350...104,441,371
Ensembl chr11:104,393,571...104,441,446
|
|
G |
Cdc37l1 |
cell division cycle 37-like 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CDC37L1 mRNA |
CTD |
PMID:15963989 |
|
NCBI chr19:28,959,049...29,008,832
Ensembl chr19:28,967,752...29,004,081
|
|
G |
Cdc42 |
cell division cycle 42 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CDC42 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:137,047,011...137,085,007
Ensembl chr 4:137,047,007...137,085,031
|
|
G |
Cdc42ep2 |
CDC42 effector protein 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CDC42EP2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:5,967,584...5,974,844
Ensembl chr19:5,965,664...5,974,844
|
|
G |
Cdc42ep3 |
CDC42 effector protein 3 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CDC42EP3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:79,641,152...79,662,520
Ensembl chr17:79,641,156...79,662,520
|
|
G |
Cdc42ep4 |
CDC42 effector protein 4 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of CDC42EP4 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr11:113,617,676...113,643,369
Ensembl chr11:113,617,676...113,642,707
|
|
G |
Cdc42se1 |
CDC42 small effector 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CDC42SE1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 3:95,135,735...95,143,735
Ensembl chr 3:95,136,043...95,143,720
|
|
G |
Cdc5l |
cell division cycle 5-like |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CDC5L mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:45,702,809...45,744,633
Ensembl chr17:45,702,810...45,744,663
|
|
G |
Cdca3 |
cell division cycle associated 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CDCA3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:124,806,533...124,810,664
Ensembl chr 6:124,806,510...124,810,664
|
|
G |
Cdcp1 |
CUB domain containing protein 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CDCP1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:122,999,870...123,045,175
Ensembl chr 9:122,999,889...123,045,103
|
|
G |
Cdh11 |
cadherin 11 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CDH11 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 8:103,358,727...103,512,125
Ensembl chr 8:103,358,727...103,512,274 Ensembl chr 8:103,358,727...103,512,274 Ensembl chr 8:103,358,727...103,512,274
|
|
G |
Cdh3 |
cadherin 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CDH3 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 8:107,237,484...107,283,543
Ensembl chr 8:107,237,523...107,283,929
|
|
G |
Cdh5 |
cadherin 5 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CDH5 mRNA |
CTD |
PMID:22659508 |
|
NCBI chr 8:104,828,247...104,871,136
Ensembl chr 8:104,828,257...104,871,143
|
|
G |
Cdk1 |
cyclin dependent kinase 1 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CDK1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
|
|
G |
Cdk10 |
cyclin dependent kinase 10 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CDK10 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 8:123,951,580...123,958,995
Ensembl chr 8:123,951,581...123,958,989
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases activity multiple interactions decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased activity of CDK2 protein ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CDK2 protein] tert-Butylhydroperoxide results in decreased expression of CDK2 mRNA |
CTD |
PMID:12766906 PMID:15336504 PMID:15606011 |
|
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
increases expression multiple interactions |
EXP ISO |
tert-Butylhydroperoxide results in increased expression of CDKN1A mRNA; tert-Butylhydroperoxide results in increased expression of CDKN1A protein [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA; ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CDKN1A protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA]; Niacinamide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1A protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1A protein] |
CTD |
PMID:12414654 PMID:12766906 PMID:12782109 PMID:15336504 PMID:15606011 PMID:18619952 PMID:22563892 PMID:35690295 More...
|
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
multiple interactions |
ISO |
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1B mRNA |
CTD |
PMID:35690295 |
|
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
|
|
G |
Cdkn1c |
cyclin dependent kinase inhibitor 1C |
multiple interactions decreases expression increases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1C mRNA]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1C mRNA] tert-Butylhydroperoxide results in decreased expression of CDKN1C mRNA |
CTD |
PMID:12419474 PMID:20847119 |
|
NCBI chr 7:143,012,076...143,014,735
Ensembl chr 7:143,012,076...143,014,787
|
|
G |
Cdkn2b |
cyclin dependent kinase inhibitor 2B |
decreases expression |
ISO EXP |
tert-Butylhydroperoxide results in decreased expression of CDKN2B mRNA |
CTD |
PMID:12419474 PMID:14729362 |
|
NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276
|
|
G |
Cdkn2c |
cyclin dependent kinase inhibitor 2C |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CDKN2C mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:109,518,073...109,523,953
Ensembl chr 4:109,518,073...109,524,386
|
|
G |
Cdkn3 |
cyclin dependent kinase inhibitor 3 |
increases expression |
EXP ISO |
tert-Butylhydroperoxide results in increased expression of CDKN3 mRNA |
CTD |
PMID:15003993 PMID:27509014 |
|
NCBI chr14:46,997,912...47,008,987
Ensembl chr14:46,997,998...47,009,126
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of CEBPA mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CEBPB mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
|
|
G |
Celf2 |
CUGBP, Elav-like family member 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CELF2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:6,544,505...7,401,345
Ensembl chr 2:6,544,505...7,514,374
|
|
G |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CELSR2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 3:108,298,164...108,323,416
Ensembl chr 3:108,298,167...108,323,383
|
|
G |
Cenpa |
centromere protein A |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CENPA mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 5:30,824,214...30,832,181
Ensembl chr 5:30,824,121...30,832,174
|
|
G |
Cenpm |
centromere protein M |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CENPM mRNA |
CTD |
PMID:15336504 |
|
NCBI chr15:82,115,694...82,128,974
Ensembl chr15:82,117,980...82,128,949
|
|
G |
Cep170 |
centrosomal protein 170 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CEP170 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:176,556,638...176,641,545
Ensembl chr 1:176,561,219...176,641,633
|
|
G |
Cep170b |
centrosomal protein 170B |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CEP170B mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:112,687,950...112,713,026
Ensembl chr12:112,686,889...112,713,026
|
|
G |
Cep192 |
centrosomal protein 192 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CEP192 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr18:67,933,124...68,018,241
Ensembl chr18:67,933,177...68,018,241
|
|
G |
Cep43 |
centrosomal protein 43 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CEP43 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:8,383,976...8,415,309
Ensembl chr17:8,384,333...8,415,636
|
|
G |
Cep57 |
centrosomal protein 57 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CEP57 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:13,717,979...13,738,698
Ensembl chr 9:13,719,088...13,738,403
|
|
G |
Cep89 |
centrosomal protein 89 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CEP89 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 7:35,096,425...35,139,255
Ensembl chr 7:35,096,460...35,138,114
|
|
G |
Cfb |
complement factor B |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CFB mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
|
|
G |
Cfi |
complement component factor i |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CFI mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 3:129,630,432...129,668,978
Ensembl chr 3:129,629,533...129,668,981
|
|
G |
Chaf1a |
chromatin assembly factor 1, subunit A |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CHAF1A mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:56,347,404...56,375,027
Ensembl chr17:56,347,439...56,379,289
|
|
G |
Chdh |
choline dehydrogenase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CHDH mRNA |
CTD |
PMID:27509014 |
|
NCBI chr14:29,730,957...29,762,423
Ensembl chr14:29,730,980...29,762,484
|
|
G |
Chek1 |
checkpoint kinase 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CHEK1 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 9:36,619,935...36,637,897
Ensembl chr 9:36,619,778...36,638,361
|
|
G |
Chka |
choline kinase alpha |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of CHKA mRNA |
CTD |
PMID:23410634 |
|
NCBI chr19:3,901,585...3,944,368
Ensembl chr19:3,901,773...3,944,369
|
|
G |
Chmp2a |
charged multivesicular body protein 2A |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CHMP2A mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 7:12,765,933...12,768,704
Ensembl chr 7:12,765,937...12,768,734
|
|
G |
Chordc1 |
cysteine and histidine rich domain containing 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CHORDC1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:18,203,563...18,225,296
Ensembl chr 9:18,203,421...18,228,738
|
|
G |
Chrdl1 |
chordin-like 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CHRDL1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr X:142,068,670...142,177,282
Ensembl chr X:142,068,670...142,177,258
|
|
G |
Chst15 |
carbohydrate sulfotransferase 15 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of CHST15 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 7:131,837,508...131,919,227
Ensembl chr 7:131,837,509...131,918,957
|
|
G |
Chst2 |
carbohydrate sulfotransferase 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CHST2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:95,282,979...95,289,323
Ensembl chr 9:95,281,345...95,288,775
|
|
G |
Clasp1 |
CLIP associating protein 1 |
decreases methylation decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased methylation of CLASP1 intron tert-Butylhydroperoxide results in decreased expression of CLASP1 mRNA |
CTD |
PMID:29432895 |
|
NCBI chr 1:118,314,976...118,537,192
Ensembl chr 1:118,316,788...118,540,408
|
|
G |
Clcn3 |
chloride channel, voltage-sensitive 3 |
decreases expression |
EXP |
tert-Butylhydroperoxide results in decreased expression of CLCN3 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 8:61,363,423...61,436,351
Ensembl chr 8:61,363,423...61,436,334
|
|
G |
Clic3 |
chloride intracellular channel 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CLIC3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:25,346,855...25,348,789
Ensembl chr 2:25,346,850...25,348,788
|
|
G |
Cln3 |
CLN3 lysosomal/endosomal transmembrane protein, battenin |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CLN3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 7:126,170,571...126,184,991
Ensembl chr 7:126,170,379...126,184,989
|
|
G |
Cln6 |
ceroid-lipofuscinosis, neuronal 6 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CLN6 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 9:62,746,067...62,759,288
Ensembl chr 9:62,746,067...62,759,288
|
|
G |
Clstn1 |
calsyntenin 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CLSTN1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:149,670,536...149,733,356
Ensembl chr 4:149,670,925...149,733,356
|
|
G |
Clu |
clusterin |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CLU mRNA |
CTD |
PMID:15963989 |
|
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
|
|
G |
Cmtm1 |
CKLF-like MARVEL transmembrane domain containing 1 |
decreases methylation |
ISO |
tert-Butylhydroperoxide results in decreased methylation of CMTM1 gene |
CTD |
PMID:29432895 |
|
NCBI chr 8:105,020,174...105,036,777
Ensembl chr 8:105,007,979...105,036,713 Ensembl chr 8:105,007,979...105,036,713
|
|
G |
Cndp2 |
CNDP dipeptidase 2 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CNDP2 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr18:84,685,590...84,703,827
Ensembl chr18:84,685,590...84,703,827
|
|
G |
Cnnm3 |
cyclin M3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CNNM3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:36,550,948...36,567,318
Ensembl chr 1:36,550,948...36,567,318
|
|
G |
Cnot8 |
CCR4-NOT transcription complex, subunit 8 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CNOT8 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:57,983,620...58,009,423
Ensembl chr11:57,994,979...58,009,420
|
|
G |
Cog5 |
component of oligomeric golgi complex 5 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of COG5 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:31,704,848...31,987,629
Ensembl chr12:31,704,868...31,987,629
|
|
G |
Cog8 |
component of oligomeric golgi complex 8 |
multiple interactions decreases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of COG8 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of COG8 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of COG8 mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr 8:107,775,341...107,783,369
Ensembl chr 8:107,772,921...107,783,321
|
|
G |
Col13a1 |
collagen, type XIII, alpha 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of COL13A1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:61,674,013...61,814,985
Ensembl chr10:61,674,015...61,814,887
|
|
G |
Col1a2 |
collagen, type I, alpha 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of COL1A2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
|
|
G |
Col3a1 |
collagen, type III, alpha 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of COL3A1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
|
|
G |
Col4a1 |
collagen, type IV, alpha 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of COL4A1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826
|
|
G |
Col4a2 |
collagen, type IV, alpha 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of COL4A2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:11,362,878...11,499,287
Ensembl chr 8:11,362,805...11,499,287
|
|
G |
Col5a1 |
collagen, type V, alpha 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of COL5A1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:27,776,393...27,929,522
Ensembl chr 2:27,776,437...27,929,526
|
|
G |
Col5a2 |
collagen, type V, alpha 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of COL5A2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:45,413,491...45,542,442
Ensembl chr 1:45,413,481...45,542,442
|
|
G |
Col6a1 |
collagen, type VI, alpha 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of COL6A1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:76,544,626...76,561,869
Ensembl chr10:76,544,626...76,562,002
|
|
G |
Col6a2 |
collagen, type VI, alpha 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of COL6A2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:76,431,590...76,459,464
Ensembl chr10:76,431,596...76,459,464
|
|
G |
Col7a1 |
collagen, type VII, alpha 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of COL7A1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:108,782,654...108,813,943
Ensembl chr 9:108,782,654...108,813,943
|
|
G |
Col8a2 |
collagen, type VIII, alpha 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of COL8A2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:126,180,613...126,208,123
Ensembl chr 4:126,180,586...126,208,123
|
|
G |
Comt |
catechol-O-methyltransferase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of COMT mRNA tert-Butylhydroperoxide results in decreased expression of COMT protein |
CTD |
PMID:12419474 PMID:24394546 |
|
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
|
|
G |
Copa |
coatomer protein complex subunit alpha |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of COPA mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:171,909,885...171,949,899
Ensembl chr 1:171,910,096...171,949,897
|
|
G |
Copb1 |
coatomer protein complex, subunit beta 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of COPB1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 7:113,814,794...113,853,915
Ensembl chr 7:113,814,794...113,853,946
|
|
G |
Cope |
coatomer protein complex, subunit epsilon |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of COPE mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:70,755,417...70,765,652
Ensembl chr 8:70,755,168...70,765,643
|
|
G |
Cops6 |
COP9 signalosome subunit 6 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of COPS6 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:138,159,364...138,162,246
Ensembl chr 5:138,159,333...138,162,908
|
|
G |
Cops8 |
COP9 signalosome subunit 8 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of COPS8 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:90,531,147...90,541,063
Ensembl chr 1:90,530,703...90,541,063
|
|
G |
Cox7a1 |
cytochrome c oxidase subunit 7A1 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of COX7A1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 7:29,883,596...29,885,455
Ensembl chr 7:29,883,569...29,885,503
|
|
G |
Cp |
ceruloplasmin |
decreases expression |
EXP |
tert-Butylhydroperoxide results in decreased expression of CP mRNA |
CTD |
PMID:14729362 |
|
NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
|
|
G |
Cpe |
carboxypeptidase E |
decreases expression increases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CPE mRNA tert-Butylhydroperoxide results in increased expression of CPE mRNA |
CTD |
PMID:12419474 PMID:15336504 |
|
NCBI chr 8:65,045,576...65,146,143
Ensembl chr 8:65,045,576...65,146,088
|
|
G |
Cpm |
carboxypeptidase M |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CPM mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:117,465,405...117,523,257
Ensembl chr10:117,465,405...117,523,257
|
|
G |
Cpne1 |
copine I |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CPNE1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:155,913,765...155,953,847
Ensembl chr 2:155,913,762...155,953,885
|
|
G |
Cpq |
carboxypeptidase Q |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CPQ mRNA |
CTD |
PMID:15336504 |
|
NCBI chr15:33,083,275...33,594,698
Ensembl chr15:33,083,275...33,594,698
|
|
G |
Crat |
carnitine acetyltransferase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CRAT mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:30,290,483...30,305,602
Ensembl chr 2:30,290,483...30,305,825
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
decreases expression multiple interactions increases phosphorylation |
ISO |
tert-Butylhydroperoxide results in decreased expression of CREB1 mRNA U 0126 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of CREB1 protein] |
CTD |
PMID:12419474 PMID:17003459 |
|
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
|
|
G |
Crip1 |
cysteine-rich protein 1 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CRIP1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr12:113,115,632...113,117,499
Ensembl chr12:113,109,936...113,117,499
|
|
G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CRISPLD2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:120,719,177...120,779,533
Ensembl chr 8:120,719,177...120,779,532
|
|
G |
Cryab |
crystallin, alpha B |
multiple interactions increases expression decreases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CRYAB mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CRYAB mRNA] tert-Butylhydroperoxide results in decreased expression of CRYAB mRNA |
CTD |
PMID:15336504 PMID:20847119 |
|
NCBI chr 9:50,657,251...50,667,936
Ensembl chr 9:50,662,625...50,667,936
|
|
G |
Cryz |
crystallin, zeta |
decreases response to substance increases expression |
EXP |
CRYZ protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of CRYZ mRNA |
CTD |
PMID:14729362 PMID:15003993 PMID:15336504 |
|
NCBI chr 3:154,302,348...154,328,819
Ensembl chr 3:154,302,348...154,328,819
|
|
G |
Csf1 |
colony stimulating factor 1 (macrophage) |
decreases response to substance |
ISO |
CSF1 protein results in decreased susceptibility to tert-Butylhydroperoxide |
CTD |
PMID:16446085 |
|
NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
|
|
G |
Csnk1d |
casein kinase 1, delta |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CSNK1D mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:120,848,535...120,882,180
Ensembl chr11:120,849,816...120,882,156
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CSPG4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:56,772,388...56,807,154
Ensembl chr 9:56,772,317...56,807,154
|
|
G |
Csprs |
component of Sp100-rs |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CSPRS mRNA |
CTD |
PMID:15003993 |
|
|
|
G |
Ctdspl |
CTD small phosphatase like |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CTDSPL mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:118,751,313...118,873,187
Ensembl chr 9:118,755,521...118,873,066
|
|
G |
Cth |
cystathionine gamma lyase |
increases activity |
ISO |
tert-Butylhydroperoxide results in increased activity of CTH protein |
CTD |
PMID:18184479 |
|
NCBI chr 3:157,599,885...157,630,718
Ensembl chr 3:157,599,885...157,630,714
|
|
G |
Ctnna1 |
catenin alpha 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CTNNA1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr18:35,251,955...35,387,829
Ensembl chr18:35,251,912...35,387,832
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions increases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
|
|
G |
Ctsb |
cathepsin B |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CTSB mRNA |
CTD |
PMID:15336504 |
|
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
|
|
G |
Ctsl |
cathepsin L |
decreases expression increases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CTSL mRNA tert-Butylhydroperoxide results in increased expression of CTSL mRNA |
CTD |
PMID:12419474 PMID:15336504 |
|
NCBI chr13:64,509,704...64,518,586
Ensembl chr13:64,507,151...64,518,704
|
|
G |
Cttn |
cortactin |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CTTN mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 7:143,989,468...144,024,743
Ensembl chr 7:143,989,470...144,024,746
|
|
G |
Cul3 |
cullin 3 |
increases expression multiple interactions |
ISO |
tert-Butylhydroperoxide results in increased expression of CUL3 mRNA; tert-Butylhydroperoxide results in increased expression of CUL3 protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CUL3 mRNA]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CUL3 mRNA]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CUL3 protein] |
CTD |
PMID:38272317 |
|
NCBI chr 1:80,242,640...80,318,426
Ensembl chr 1:80,242,640...80,318,197
|
|
G |
Cul4a |
cullin 4A |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CUL4A mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:13,155,623...13,197,940
Ensembl chr 8:13,155,621...13,197,940
|
|
G |
Cux1 |
cut-like homeobox 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CUX1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:136,276,989...136,596,429
Ensembl chr 5:136,276,989...136,596,344
|
|
G |
Cxadr |
coxsackie virus and adenovirus receptor |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CXADR mRNA |
CTD |
PMID:15336504 |
|
NCBI chr16:78,098,114...78,156,673
Ensembl chr16:78,098,377...78,156,662
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CXCL1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of CXCL10 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
multiple interactions increases expression increases secretion affects expression |
ISO |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of CXCL8 protein]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 protein]; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of CXCL8 protein]; [Catechin co-treated with tert-Butylhydroperoxide co-treated with Hydrocortisone] results in decreased secretion of CXCL8 protein; [Grape Seed Extract co-treated with tert-Butylhydroperoxide co-treated with Hydrocortisone] results in decreased secretion of CXCL8 protein; [tert-Butylhydroperoxide co-treated with Hydrocortisone] results in decreased secretion of CXCL8 protein; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 protein]; W 7 inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of CXCL8 protein] tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA; tert-Butylhydroperoxide results in increased expression of CXCL8 protein tert-Butylhydroperoxide affects the expression of CXCL8 mRNA |
CTD |
PMID:15336504 PMID:17129690 PMID:23410634 PMID:28063877 PMID:29111459 PMID:29935159 More...
|
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CXCL2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CXCL1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
multiple interactions increases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCR4 mRNA]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCR4 mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
|
|
G |
Cxxc5 |
CXXC finger 5 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CXXC5 mRNA |
CTD |
PMID:29432895 |
|
NCBI chr18:35,962,432...35,994,746
Ensembl chr18:35,962,450...35,994,741
|
|
G |
Cyb561 |
cytochrome b-561 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CYB561 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:105,824,528...105,844,157
Ensembl chr11:105,824,528...105,844,162
|
|
G |
Cyb5d2 |
cytochrome b5 domain containing 2 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of CYB5D2 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr11:72,668,058...72,686,665
Ensembl chr11:72,668,058...72,686,968
|
|
G |
Cyb5r2 |
cytochrome b5 reductase 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CYB5R2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 7:107,347,653...107,357,407
Ensembl chr 7:107,347,662...107,357,239
|
|
G |
Cybc1 |
cytochrome b 245 chaperone 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of CYBC1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:121,113,414...121,120,135
Ensembl chr11:121,113,414...121,120,148
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions affects localization |
ISO |
hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of CYCS protein] |
CTD |
PMID:18552516 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Cygb |
cytoglobin |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CYGB mRNA |
CTD |
PMID:27509014 |
|
NCBI chr11:116,536,421...116,544,887
Ensembl chr11:116,536,421...116,545,139
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CYP1B1 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of CYP24A1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 2:170,324,877...170,339,065
Ensembl chr 2:170,324,628...170,339,065
|
|
G |
Cyria |
CYFIP related Rac1 interactor A |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of CYRIA mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:12,312,136...12,430,966
Ensembl chr12:12,312,140...12,430,966
|
|
G |
Dap3 |
death associated protein 3 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of DAP3 mRNA |
CTD |
PMID:14729362 |
|
NCBI chr 3:88,828,110...88,858,504
Ensembl chr 3:88,828,110...88,858,488
|
|
G |
Dapk1 |
death associated protein kinase 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DAPK1 mRNA |
CTD |
PMID:12419474 PMID:15336504 |
|
NCBI chr13:60,749,506...60,911,005
Ensembl chr13:60,749,761...60,911,005
|
|
G |
Dars1 |
aspartyl-tRNA synthetase 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DARS1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:128,291,444...128,345,153
Ensembl chr 1:128,291,444...128,345,105
|
|
G |
Dazap2 |
DAZ associated protein 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DAZAP2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr15:100,513,543...100,518,642
Ensembl chr15:100,513,230...100,518,642
|
|
G |
Dbi |
diazepam binding inhibitor |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DBI mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:120,041,010...120,048,826
Ensembl chr 1:120,041,010...120,048,808
|
|
G |
Dcaf7 |
DDB1 and CUL4 associated factor 7 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DCAF7 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:105,927,698...105,950,150
Ensembl chr11:105,927,698...105,950,150
|
|
G |
Dctn5 |
dynactin 5 |
decreases methylation |
ISO |
tert-Butylhydroperoxide results in decreased methylation of DCTN5 gene |
CTD |
PMID:29432895 |
|
NCBI chr 7:121,732,264...121,748,267
Ensembl chr 7:121,732,264...121,748,267
|
|
G |
Ddb2 |
damage specific DNA binding protein 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DDB2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:91,041,924...91,067,465
Ensembl chr 2:91,041,917...91,067,327
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
ISO |
tert-Butylhydroperoxide results in increased expression of DDIT3 mRNA; tert-Butylhydroperoxide results in increased expression of DDIT3 protein Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein] |
CTD |
PMID:12414654 PMID:22659508 PMID:24394546 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of DDIT4 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr10:59,785,497...59,787,592
Ensembl chr10:59,785,491...59,787,656
|
|
G |
Ddr1 |
discoidin domain receptor family, member 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DDR1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513
|
|
G |
Ddx11 |
DEAD/H box helicase 11 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DDX11 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:66,430,508...66,459,169
Ensembl chr17:66,430,515...66,459,169
|
|
G |
Ddx21 |
DExD box helicase 21 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DDX21 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:62,416,026...62,438,077
Ensembl chr10:62,416,030...62,438,060
|
|
G |
Ddx42 |
DEAD box helicase 42 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DDX42 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr11:106,107,715...106,139,966
Ensembl chr11:106,107,752...106,139,965
|
|
G |
Ddx43 |
DEAD box helicase 43 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DDX43 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:78,303,059...78,330,871
Ensembl chr 9:78,303,059...78,330,869
|
|
G |
Ddx50 |
DExD box helicase 50 |
decreases expression |
EXP |
tert-Butylhydroperoxide results in decreased expression of DDX50 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr10:62,451,571...62,487,260
Ensembl chr10:62,451,674...62,486,997
|
|
G |
Ddx52 |
DExD box helicase 52 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DDX52 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:83,831,659...83,853,914
Ensembl chr11:83,832,888...83,853,914
|
|
G |
Ddx56 |
DEAD box helicase 56 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DDX56 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:6,205,343...6,218,389
Ensembl chr11:6,208,919...6,217,772
|
|
G |
Ddx6 |
DEAD-box helicase 6 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of DDX6 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 9:44,514,113...44,552,028
Ensembl chr 9:44,516,189...44,552,028
|
|
G |
Dennd3 |
DENN domain containing 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DENND3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr15:73,384,333...73,444,091
Ensembl chr15:73,384,409...73,444,091
|
|
G |
Depp1 |
DEPP1 autophagy regulator |
multiple interactions increases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DEPP1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DEPP1 mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr 6:116,627,645...116,629,808
Ensembl chr 6:116,627,570...116,629,755
|
|
G |
Derl1 |
Der1-like domain family, member 1 |
decreases expression |
EXP |
tert-Butylhydroperoxide results in decreased expression of DERL1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr15:57,732,898...57,755,814
Ensembl chr15:57,732,898...57,755,844
|
|
G |
Dffb |
DNA fragmentation factor, beta subunit |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DFFB mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 4:154,048,904...154,059,578
Ensembl chr 4:154,048,906...154,059,583
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of DGAT2 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 7:98,802,870...98,831,920
Ensembl chr 7:98,802,865...98,831,926
|
|
G |
Dhps |
deoxyhypusine synthase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DHPS mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:85,798,106...85,801,790
Ensembl chr 8:85,798,386...85,801,791
|
|
G |
Dhx9 |
DExH-box helicase 9 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DHX9 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:153,331,506...153,363,464
Ensembl chr 1:153,331,504...153,363,406
|
|
G |
Dimt1 |
DIM1 rRNA methyltransferase and ribosome maturation factor |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DIMT1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr13:107,083,637...107,097,833
Ensembl chr13:107,083,635...107,096,732
|
|
G |
Dip2c |
disco interacting protein 2 homolog C |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DIP2C mRNA |
CTD |
PMID:15336504 |
|
NCBI chr13:9,326,530...9,718,964
Ensembl chr13:9,326,564...9,718,964
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DKK1 mRNA |
CTD |
PMID:12414654 PMID:15336504 |
|
NCBI chr19:30,523,276...30,526,896
Ensembl chr19:30,523,263...30,527,065
|
|
G |
Dlg1 |
discs large MAGUK scaffold protein 1 |
multiple interactions increases expression |
ISO |
[rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DLG1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DLG1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr16:31,482,261...31,692,174
Ensembl chr16:31,482,261...31,693,947
|
|
G |
Dlg3 |
discs large MAGUK scaffold protein 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DLG3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr X:99,811,200...99,862,016
Ensembl chr X:99,811,328...99,862,016
|
|
G |
Dlgap4 |
DLG associated protein 4 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DLGAP4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:156,455,431...156,606,283
Ensembl chr 2:156,455,625...156,606,283
|
|
G |
Dlgap5 |
DLG associated protein 5 |
increases expression affects expression |
EXP ISO |
tert-Butylhydroperoxide results in increased expression of DLGAP5 mRNA tert-Butylhydroperoxide affects the expression of DLGAP5 mRNA |
CTD |
PMID:15003993 PMID:23410634 |
|
NCBI chr14:47,625,238...47,655,657
Ensembl chr14:47,625,236...47,655,864
|
|
G |
Dlx2 |
distal-less homeobox 2 |
increases expression |
EXP ISO |
tert-Butylhydroperoxide results in increased expression of DLX2 mRNA |
CTD |
PMID:14729362 PMID:29432895 |
|
NCBI chr 2:71,373,752...71,377,095
Ensembl chr 2:71,373,752...71,377,098
|
|
G |
Dmpk |
dystrophia myotonica-protein kinase |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of DMPK mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 7:18,817,571...18,827,746
Ensembl chr 7:18,817,774...18,827,746
|
|
G |
Dnaaf2 |
dynein, axonemal assembly factor 2 |
multiple interactions decreases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of DNAAF2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of DNAAF2 mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr12:69,235,861...69,245,203
Ensembl chr12:69,235,861...69,245,203
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DNAJB1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:84,334,804...84,339,282
Ensembl chr 8:84,334,822...84,339,282
|
|
G |
Dnajb11 |
DnaJ heat shock protein family (Hsp40) member B11 |
decreases expression |
EXP |
tert-Butylhydroperoxide results in decreased expression of DNAJB11 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr16:22,676,595...22,698,384
Ensembl chr16:22,676,595...22,698,384
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DNAJB4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 3:151,887,217...151,915,720
Ensembl chr 3:151,884,148...151,915,939
|
|
G |
Dnajb7 |
DnaJ heat shock protein family (Hsp40) member B7 |
decreases methylation |
ISO |
tert-Butylhydroperoxide results in decreased methylation of DNAJB7 intron |
CTD |
PMID:29432895 |
|
NCBI chr15:81,291,289...81,292,474
Ensembl chr15:81,291,127...81,292,500
|
|
G |
Dnase2a |
deoxyribonuclease II alpha |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DNASE2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:85,635,384...85,638,332
Ensembl chr 8:85,635,189...85,649,544
|
|
G |
Dnm2 |
dynamin 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DNM2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:21,336,167...21,419,055
Ensembl chr 9:21,336,204...21,419,055
|
|
G |
Dnmbp |
dynamin binding protein |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DNMBP mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:43,835,259...43,930,930
Ensembl chr19:43,835,260...43,928,630
|
|
G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DNPH1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr17:46,807,715...46,810,544
Ensembl chr17:46,807,637...46,810,550
|
|
G |
Dock2 |
dedicator of cyto-kinesis 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DOCK2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:34,176,815...34,674,732
Ensembl chr11:34,176,815...34,674,719
|
|
G |
Dock4 |
dedicator of cytokinesis 4 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DOCK4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:40,495,956...40,896,873
Ensembl chr12:40,495,951...40,896,873
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DPP4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:62,160,417...62,242,635
Ensembl chr 2:62,160,417...62,242,575
|
|
G |
Dpy19l1 |
dpy-19 like C-mannosyltransferase 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DPY19L1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:24,323,074...24,414,436
Ensembl chr 9:24,323,072...24,414,436
|
|
G |
Dpysl3 |
dihydropyrimidinase-like 3 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DPYSL3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr18:43,454,044...43,571,354
Ensembl chr18:43,454,049...43,571,351
|
|
G |
Drap1 |
DR1 associated protein 1 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of DRAP1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr19:5,472,832...5,475,007
Ensembl chr19:5,472,833...5,475,007
|
|
G |
Dsc3 |
desmocollin 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DSC3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr18:20,093,987...20,135,465
Ensembl chr18:20,093,987...20,135,408
|
|
G |
Dst |
dystonin |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DST mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:33,946,969...34,347,743
Ensembl chr 1:33,947,306...34,347,742
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of DUSP1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
multiple interactions increases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DUSP10 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DUSP10 mRNA] |
CTD |
PMID:15336504 PMID:20847119 |
|
NCBI chr 1:183,766,575...183,807,833
Ensembl chr 1:183,745,499...183,807,833
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of DUSP5 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:53,517,576...53,530,240
Ensembl chr19:53,517,540...53,530,862
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
decreases expression increases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DUSP6 mRNA tert-Butylhydroperoxide results in increased expression of DUSP6 mRNA |
CTD |
PMID:15336504 PMID:17003459 |
|
NCBI chr10:99,098,676...99,103,351
Ensembl chr10:99,099,093...99,103,351
|
|
G |
Dusp9 |
dual specificity phosphatase 9 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of DUSP9 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr X:72,682,995...72,687,120
Ensembl chr X:72,683,025...72,687,120
|
|
G |
Dut |
deoxyuridine triphosphatase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DUT mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:125,089,168...125,100,969
Ensembl chr 2:125,089,110...125,100,528
|
|
G |
Dvl3 |
dishevelled segment polarity protein 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DVL3 mRNA |
CTD |
PMID:29432895 |
|
NCBI chr16:20,335,694...20,352,763
Ensembl chr16:20,335,732...20,352,760
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DYNLL1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:115,435,129...115,438,995
Ensembl chr 5:115,435,169...115,439,058
|
|
G |
Dynlrb1 |
dynein light chain roadblock-type 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of DYNLRB1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:155,078,453...155,092,197
Ensembl chr 2:155,078,453...155,092,197
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of E2F1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812
|
|
G |
Ech1 |
enoyl coenzyme A hydratase 1, peroxisomal |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ECH1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 7:28,524,763...28,531,664
Ensembl chr 7:28,524,642...28,531,672
|
|
G |
Echdc2 |
enoyl Coenzyme A hydratase domain containing 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ECHDC2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:108,022,630...108,036,505
Ensembl chr 4:108,022,634...108,036,505
|
|
G |
Echs1 |
enoyl Coenzyme A hydratase, short chain, 1, mitochondrial |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ECHS1 protein |
CTD |
PMID:24394546 |
|
NCBI chr 7:139,685,623...139,696,334
Ensembl chr 7:139,685,623...139,696,389
|
|
G |
Eci1 |
enoyl-Coenzyme A delta isomerase 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ECI1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:24,645,657...24,658,290
Ensembl chr17:24,645,615...24,658,322
|
|
G |
Ecsit |
ECSIT signalling integrator |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ECSIT mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:21,982,731...21,997,648
Ensembl chr 9:21,983,542...21,996,734
|
|
G |
Edil3 |
EGF-like repeats and discoidin I-like domains 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of EDIL3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr13:88,969,591...89,471,344
Ensembl chr13:88,969,591...89,471,342
|
|
G |
Edn1 |
endothelin 1 |
increases expression affects expression |
ISO |
tert-Butylhydroperoxide results in increased expression of EDN1 mRNA tert-Butylhydroperoxide affects the expression of EDN1 mRNA |
CTD |
PMID:12414654 PMID:23410634 |
|
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of EEF2 protein |
CTD |
PMID:16469450 |
|
NCBI chr10:81,012,465...81,018,343
Ensembl chr10:81,012,465...81,018,332
|
|
G |
Efemp1 |
epidermal growth factor-containing fibulin-like extracellular matrix protein 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of EFEMP1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:28,803,154...28,876,743
Ensembl chr11:28,803,204...28,876,743
|
|
G |
Efhd1 |
EF hand domain containing 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of EFHD1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:87,192,075...87,238,563
Ensembl chr 1:87,192,085...87,238,561
|
|
G |
Efna4 |
ephrin A4 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of EFNA4 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 3:89,240,700...89,245,335
Ensembl chr 3:89,240,697...89,245,335
|
|
G |
Efs |
embryonal Fyn-associated substrate |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of EFS mRNA |
CTD |
PMID:15336504 |
|
NCBI chr14:55,154,087...55,164,222
Ensembl chr14:55,153,992...55,163,583
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA] |
CTD |
PMID:35690295 |
|
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
|
|
G |
Egr1 |
early growth response 1 |
increases expression affects expression |
ISO |
tert-Butylhydroperoxide results in increased expression of EGR1 mRNA tert-Butylhydroperoxide affects the expression of EGR1 mRNA |
CTD |
PMID:12414654 PMID:23410634 |
|
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of EIF2AK2 mRNA |
CTD |
PMID:14729362 PMID:15003993 |
|
NCBI chr17:79,157,933...79,190,001
Ensembl chr17:79,159,993...79,190,002
|
|
G |
Eif2b4 |
eukaryotic translation initiation factor 2B, subunit 4 delta |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of EIF2B4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:31,344,902...31,350,483
Ensembl chr 5:31,344,902...31,350,774
|
|
G |
Eif3m |
eukaryotic translation initiation factor 3, subunit M |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of EIF3M mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:104,830,001...104,847,372
Ensembl chr 2:104,830,001...104,847,425
|
|
G |
Eif5 |
eukaryotic translation initiation factor 5 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of EIF5 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:111,504,535...111,513,187
Ensembl chr12:111,504,450...111,513,186
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of EIF5B mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:38,037,091...38,094,660
Ensembl chr 1:38,037,091...38,094,660
|
|
G |
Elavl1 |
ELAV like RNA binding protein 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ELAVL1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:4,334,781...4,375,104
Ensembl chr 8:4,335,382...4,375,413
|
|
G |
Elf1 |
E74 like ETS transcription factor 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ELF1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr14:79,718,619...79,819,916
Ensembl chr14:79,718,634...79,819,934
|
|
G |
Elf5 |
E74-like factor 5 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ELF5 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 2:103,242,443...103,281,334
Ensembl chr 2:103,242,033...103,281,334
|
|
G |
Elob |
elongin B |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ELOB mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:24,043,714...24,048,083
Ensembl chr17:24,043,712...24,048,110
|
|
G |
Eme1 |
essential meiotic structure-specific endonuclease 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of EME1 mRNA |
CTD |
PMID:27509014 |
|
NCBI chr11:94,535,798...94,544,611
Ensembl chr11:94,535,822...94,544,790
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of EMILIN1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 5:31,070,729...31,078,623
Ensembl chr 5:31,070,746...31,078,621
|
|
G |
Eml1 |
echinoderm microtubule associated protein like 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of EML1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:108,337,265...108,505,835
Ensembl chr12:108,337,216...108,505,876
|
|
G |
Eml4 |
echinoderm microtubule associated protein like 4 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of EML4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:83,658,341...83,787,790
Ensembl chr17:83,658,360...83,787,790
|
|
G |
Emp3 |
epithelial membrane protein 3 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of EMP3 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 7:45,567,447...45,570,850
Ensembl chr 7:45,567,447...45,570,828
|
|
G |
Eng |
endoglin |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ENG mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:32,536,607...32,572,681
Ensembl chr 2:32,536,607...32,572,681
|
|
G |
Epb41l2 |
erythrocyte membrane protein band 4.1 like 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of EPB41L2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:25,235,680...25,399,413
Ensembl chr10:25,235,696...25,399,417
|
|
G |
Epb42 |
erythrocyte membrane protein band 4.2 |
increases degradation |
ISO |
tert-Butylhydroperoxide results in increased degradation of EPB42 protein |
CTD |
PMID:15040847 |
|
NCBI chr 2:120,848,372...120,867,358
Ensembl chr 2:120,848,372...120,867,553
|
|
G |
Ephb2 |
Eph receptor B2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of EPHB2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:136,374,850...136,563,637
Ensembl chr 4:136,374,850...136,563,299
|
|
G |
Ephb4 |
Eph receptor B4 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of EPHB4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:137,348,371...137,372,784
Ensembl chr 5:137,348,371...137,376,931
|
|
G |
Ephx1 |
epoxide hydrolase 1, microsomal |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of EPHX1 mRNA |
CTD |
PMID:21382384 |
|
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
|
|
G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of EPHX2 mRNA |
CTD |
PMID:14729362 |
|
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ERBB2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ERBB4 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218
|
|
G |
Erbin |
Erbb2 interacting protein |
multiple interactions increases expression |
ISO |
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of ERBIN mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr13:103,955,294...104,057,094
Ensembl chr13:103,955,295...104,057,022
|
|
G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ERCC5 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:44,184,084...44,220,399
Ensembl chr 1:44,186,904...44,220,420
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signalling 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein] |
CTD |
PMID:24394546 |
|
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ERP29 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:121,582,816...121,590,537
Ensembl chr 5:121,566,653...121,590,569
|
|
G |
Esm1 |
endothelial cell-specific molecule 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ESM1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr13:113,346,193...113,354,638
Ensembl chr13:113,346,193...113,354,632
|
|
G |
Ess2 |
ess-2 splicing factor |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ESS2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr16:17,718,573...17,729,225
Ensembl chr16:17,718,573...17,729,212
|
|
G |
Etf1 |
eukaryotic translation termination factor 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ETF1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr18:35,035,838...35,065,060
Ensembl chr18:35,035,838...35,065,060
|
|
G |
Etfa |
electron transferring flavoprotein, alpha polypeptide |
multiple interactions increases expression decreases expression |
ISO |
ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]; pyrazolanthrone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ETFA protein] tert-Butylhydroperoxide results in decreased expression of ETFA protein |
CTD |
PMID:24394546 |
|
NCBI chr 9:55,361,720...55,419,528
Ensembl chr 9:55,361,792...55,419,527
|
|
G |
Etfb |
electron transferring flavoprotein, beta polypeptide |
decreases expression increases methylation |
ISO |
tert-Butylhydroperoxide results in decreased expression of ETFB mRNA tert-Butylhydroperoxide results in increased methylation of ETFB gene |
CTD |
PMID:15336504 PMID:29432895 |
|
NCBI chr 7:43,093,496...43,107,224
Ensembl chr 7:43,093,507...43,107,224
|
|
G |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ETS1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 9:32,547,501...32,669,116
Ensembl chr 9:32,547,517...32,669,116
|
|
G |
Ets2 |
E26 avian leukemia oncogene 2, 3' domain |
decreases expression increases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ETS2 mRNA tert-Butylhydroperoxide results in increased expression of ETS2 mRNA |
CTD |
PMID:12419474 PMID:15336504 |
|
NCBI chr16:95,503,274...95,522,093
Ensembl chr16:95,502,942...95,522,095
|
|
G |
Etv3 |
ets variant 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of ETV3 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 3:87,432,891...87,447,463
Ensembl chr 3:87,432,714...87,447,463
|
|
G |
Etv4 |
ets variant 4 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of ETV4 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr11:101,660,573...101,677,963
Ensembl chr11:101,660,568...101,676,197
|
|
G |
Etv5 |
ets variant 5 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of ETV5 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr16:22,200,063...22,258,320
Ensembl chr16:22,200,059...22,258,469
|
|
G |
Exo1 |
exonuclease 1 |
multiple interactions |
ISO |
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA] |
CTD |
PMID:35690295 |
|
NCBI chr 1:175,708,334...175,738,962
Ensembl chr 1:175,708,147...175,741,055
|
|
G |
Exoc7 |
exocyst complex component 7 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of EXOC7 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:116,178,823...116,197,574
Ensembl chr11:116,178,827...116,198,059
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of EZH2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
|
|
G |
Ezr |
ezrin |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of EZR mRNA |
CTD |
PMID:12419474 |
|
NCBI chr17:7,005,530...7,050,179
Ensembl chr17:7,005,440...7,050,183
|
|
G |
F2rl1 |
F2R like trypsin receptor 1 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of F2RL1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr13:95,648,226...95,661,748
Ensembl chr13:95,648,240...95,661,735
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FAH protein |
CTD |
PMID:24394546 |
|
NCBI chr 7:84,234,367...84,255,150
Ensembl chr 7:84,234,367...84,255,930
|
|
G |
Fam110b |
family with sequence similarity 110, member B |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FAM110B mRNA |
CTD |
PMID:29432895 |
|
NCBI chr 4:5,644,009...5,801,101
Ensembl chr 4:5,644,090...6,108,223
|
|
G |
Fam111a |
family with sequence similarity 111, member A |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FAM111A mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:12,550,874...12,567,133
Ensembl chr19:12,523,104...12,567,132
|
|
G |
Fam13b |
family with sequence similarity 13, member B |
decreases expression |
EXP |
tert-Butylhydroperoxide results in decreased expression of FAM13B mRNA |
CTD |
PMID:15003993 |
|
NCBI chr18:34,573,624...34,656,096
Ensembl chr18:34,575,404...34,639,884
|
|
G |
Fam171a1 |
family with sequence similarity 171, member A1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FAM171A1 mRNA |
CTD |
PMID:29432895 |
|
NCBI chr 2:3,115,261...3,228,843
Ensembl chr 2:3,115,261...3,228,843
|
|
G |
Fam210a |
family with sequence similarity 210, member A |
multiple interactions increases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FAM210A mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FAM210A mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr18:68,393,248...68,433,404
Ensembl chr18:68,393,258...68,433,404
|
|
G |
Fanci |
Fanconi anemia, complementation group I |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FANCI mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 7:79,042,056...79,100,013
Ensembl chr 7:79,041,677...79,100,012
|
|
G |
Farp1 |
FERM, ARH/RhoGEF and pleckstrin domain protein 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FARP1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr14:121,272,563...121,521,156
Ensembl chr14:121,272,612...121,521,156
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FAS mRNA |
CTD |
PMID:12414654 PMID:27509014 |
|
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fastk |
Fas-activated serine/threonine kinase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FASTK mRNA |
CTD |
PMID:12419474 PMID:15336504 |
|
NCBI chr 5:24,646,036...24,650,280
Ensembl chr 5:24,643,438...24,650,285
|
|
G |
Fbln1 |
fibulin 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FBLN1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr15:85,090,150...85,170,495
Ensembl chr15:85,090,150...85,170,736
|
|
G |
Fbxo30 |
F-box protein 30 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FBXO30 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr10:11,157,009...11,181,494
Ensembl chr10:11,157,074...11,173,796
|
|
G |
Fdps |
farnesyl diphosphate synthetase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FDPS mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 3:89,000,895...89,009,274
Ensembl chr 3:89,000,895...89,009,266
|
|
G |
Fdx1 |
ferredoxin 1 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of FDX1 mRNA |
CTD |
PMID:14729362 PMID:15336504 |
|
NCBI chr 9:51,854,323...51,874,902
Ensembl chr 9:51,854,606...51,874,856
|
|
G |
Fdxr |
ferredoxin reductase |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FDXR mRNA |
CTD |
PMID:12414654 PMID:27509014 |
|
NCBI chr11:115,158,850...115,167,925
Ensembl chr11:115,158,850...115,167,876
|
|
G |
Fen1 |
flap structure specific endonuclease 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FEN1 mRNA |
CTD |
PMID:12414654 PMID:15336504 |
|
NCBI chr19:10,176,496...10,181,757
Ensembl chr19:10,176,496...10,181,533
|
|
G |
Fermt2 |
fermitin family member 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FERMT2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr14:45,696,252...45,767,767
Ensembl chr14:45,696,252...45,767,575
|
|
G |
Fgg |
fibrinogen gamma chain |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FGG mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 3:82,915,031...82,922,363
Ensembl chr 3:82,915,031...82,922,356
|
|
G |
Fh1 |
fumarate hydratase 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FH mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:175,428,944...175,453,201
Ensembl chr 1:175,427,940...175,453,201
|
|
G |
Fhl1 |
four and a half LIM domains 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FHL1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr X:55,776,569...55,838,704
Ensembl chr X:55,777,147...55,838,706
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FHL2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:43,162,233...43,237,501
Ensembl chr 1:43,162,234...43,236,144
|
|
G |
Fhod3 |
formin homology 2 domain containing 3 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FHOD3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr18:24,841,445...25,266,564
Ensembl chr18:24,841,680...25,266,558
|
|
G |
Fibp |
fibroblast growth factor (acidic) intracellular binding protein |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FIBP mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:5,510,626...5,515,080
Ensembl chr19:5,510,643...5,515,079
|
|
G |
Fis1 |
fission, mitochondrial 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FIS1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:136,982,129...136,995,088
Ensembl chr 5:136,982,129...136,995,088
|
|
G |
Fjx1 |
four jointed box 1 |
multiple interactions decreases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of FJX1 mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr 2:102,279,711...102,282,137
Ensembl chr 2:102,279,711...102,282,844
|
|
G |
Fkbp1a |
FK506 binding protein 1a |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FKBP1A mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:151,384,403...151,403,611
Ensembl chr 2:151,384,403...151,403,612
|
|
G |
Fkbp8 |
FK506 binding protein 8 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FKBP8 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:70,980,371...70,987,978
Ensembl chr 8:70,980,374...70,987,978
|
|
G |
Flnb |
filamin, beta |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FLNB mRNA |
CTD |
PMID:15336504 |
|
NCBI chr14:14,518,185...14,651,852
Ensembl chr14:14,518,185...14,651,816
|
|
G |
Fmo1 |
flavin containing monooxygenase 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FMO1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:162,657,130...162,694,170
Ensembl chr 1:162,657,130...162,694,179
|
|
G |
Fn1 |
fibronectin 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FN1 mRNA |
CTD |
PMID:15963989 |
|
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
|
|
G |
Folr1 |
folate receptor alpha |
increases expression decreases expression |
EXP ISO |
tert-Butylhydroperoxide results in increased expression of FOLR1 mRNA tert-Butylhydroperoxide results in decreased expression of FOLR1 mRNA |
CTD |
PMID:14729362 PMID:15003993 PMID:22956110 |
|
NCBI chr 7:101,507,551...101,519,974
Ensembl chr 7:101,507,538...101,519,995
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
decreases expression multiple interactions increases expression increases methylation |
ISO EXP |
tert-Butylhydroperoxide results in decreased expression of FOS mRNA CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; Glutathione inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; Thiourea inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA] tert-Butylhydroperoxide results in increased methylation of FOS gene |
CTD |
PMID:12419474 PMID:15105052 PMID:27509014 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Fosl1 |
fos-like antigen 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FOSL1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:5,497,726...5,505,966
Ensembl chr19:5,497,575...5,505,974
|
|
G |
Foxd1 |
forkhead box D1 |
decreases expression increases expression |
EXP ISO |
tert-Butylhydroperoxide results in decreased expression of FOXD1 mRNA tert-Butylhydroperoxide results in increased expression of FOXD1 mRNA |
CTD |
PMID:15003993 PMID:15336504 |
|
NCBI chr13:98,490,753...98,493,213
Ensembl chr13:98,490,750...98,495,813
|
|
G |
Foxm1 |
forkhead box M1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FOXM1 mRNA |
CTD |
PMID:12414654 PMID:15336504 |
|
NCBI chr 6:128,339,957...128,352,849
Ensembl chr 6:128,339,930...128,353,109
|
|
G |
Ftl1 |
ferritin light polypeptide 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FTL mRNA |
CTD |
PMID:12414654 PMID:15963989 |
|
NCBI chr 7:45,107,368...45,109,310
Ensembl chr 7:45,107,368...45,109,308
|
|
G |
Fubp1 |
far upstream element (FUSE) binding protein 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of FUBP1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 3:151,916,059...151,942,467
Ensembl chr 3:151,916,059...151,942,463
|
|
G |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
increases expression |
ISO EXP |
tert-Butylhydroperoxide results in increased expression of FXYD5 mRNA |
CTD |
PMID:14729362 PMID:15003993 PMID:15336504 |
|
NCBI chr 7:30,732,153...30,741,565
Ensembl chr 7:30,732,147...30,741,906
|
|
G |
Fyco1 |
FYVE and coiled-coil domain containing 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FYCO1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:123,618,565...123,681,110
Ensembl chr 9:123,618,565...123,680,964
|
|
G |
Fzd1 |
frizzled class receptor 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FZD1 mRNA |
CTD |
PMID:29432895 |
|
NCBI chr 5:4,803,839...4,808,216
Ensembl chr 5:4,803,839...4,808,035
|
|
G |
Fzr1 |
fizzy and cell division cycle 20 related 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of FZR1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:81,202,713...81,214,204
Ensembl chr10:81,202,056...81,214,350
|
|
G |
G0s2 |
G0/G1 switch gene 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of G0S2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:192,954,468...192,955,496
Ensembl chr 1:192,954,469...192,955,525
|
|
G |
G6pd2 |
glucose-6-phosphate dehydrogenase 2 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of G6PD2 mRNA |
CTD |
PMID:14729362 |
|
NCBI chr 5:61,966,186...61,967,820
Ensembl chr 5:61,966,159...61,968,506
|
|
G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
decreases activity increases activity |
ISO EXP |
tert-Butylhydroperoxide results in decreased activity of G6PD protein tert-Butylhydroperoxide results in increased activity of G6PD protein |
CTD |
PMID:12628296 PMID:15336504 PMID:16928893 |
|
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible 45 beta |
decreases expression affects expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GADD45B mRNA tert-Butylhydroperoxide affects the expression of GADD45B mRNA |
CTD |
PMID:15336504 PMID:23410634 |
|
NCBI chr10:80,765,925...80,768,038
Ensembl chr10:80,765,907...80,768,038
|
|
G |
Gak |
cyclin G associated kinase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GAK mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:108,716,973...108,777,643
Ensembl chr 5:108,717,277...108,777,621
|
|
G |
Galm |
galactose mutarotase |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GALM mRNA |
CTD |
PMID:15003993 |
|
NCBI chr17:80,434,886...80,492,461
Ensembl chr17:80,434,900...80,492,530
|
|
G |
Galns |
galactosamine (N-acetyl)-6-sulfatase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GALNS mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:123,304,976...123,338,226
Ensembl chr 8:123,304,981...123,338,202
|
|
G |
Galnt1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GALNT1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr18:24,338,401...24,419,873
Ensembl chr18:24,338,401...24,419,875
|
|
G |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
decreases methylation increases methylation |
ISO |
tert-Butylhydroperoxide results in decreased methylation of GALNT3 intron tert-Butylhydroperoxide results in increased methylation of GALNT3 intron |
CTD |
PMID:29432895 |
|
NCBI chr 2:65,913,110...65,955,217
Ensembl chr 2:65,913,110...65,955,338
|
|
G |
Galnt6 |
polypeptide N-acetylgalactosaminyltransferase 6 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GALNT6 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr15:100,587,796...100,627,257
Ensembl chr15:100,589,694...100,627,257
|
|
G |
Ganab |
alpha glucosidase 2 alpha neutral subunit |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GANAB mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:8,875,440...8,894,098
Ensembl chr19:8,875,435...8,894,036
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GAPDH protein |
CTD |
PMID:11295360 |
|
NCBI chr 6:125,138,812...125,143,450
Ensembl chr 6:125,138,678...125,143,430
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
decreases expression |
EXP |
tert-Butylhydroperoxide results in decreased expression of GARS1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 6:55,014,986...55,056,489
Ensembl chr 6:55,014,992...55,056,485
|
|
G |
Gas2 |
growth arrest specific 2 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GAS2 mRNA |
CTD |
PMID:14729362 |
|
NCBI chr 7:51,511,560...51,644,753
Ensembl chr 7:51,511,763...51,644,723
|
|
G |
Gas2l1 |
growth arrest-specific 2 like 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GAS2L1 mRNA |
CTD |
PMID:29432895 |
|
NCBI chr11:5,004,131...5,015,351
Ensembl chr11:5,004,132...5,015,327
|
|
G |
Gata6 |
GATA binding protein 6 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GATA6 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr18:11,052,510...11,085,636
Ensembl chr18:11,052,064...11,085,635
|
|
G |
Gatd3a |
glutamine amidotransferase like class 1 domain containing 3A |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GATD3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:77,997,900...78,005,589
Ensembl chr10:77,997,900...78,005,616
|
|
G |
Gbp2 |
guanylate binding protein 2 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GBP2 mRNA |
CTD |
PMID:14729362 PMID:15003993 |
|
NCBI chr 3:142,326,424...142,343,769
Ensembl chr 3:142,326,363...142,343,769
|
|
G |
Gbp3 |
guanylate binding protein 3 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GBP3 mRNA |
CTD |
PMID:14729362 PMID:15003993 |
|
NCBI chr 3:142,265,781...142,278,974
Ensembl chr 3:142,265,787...142,278,970
|
|
G |
Gbp9 |
guanylate-binding protein 9 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GBP6 mRNA |
CTD |
PMID:14729362 PMID:15003993 |
|
NCBI chr 5:105,224,331...105,258,255
Ensembl chr 5:105,225,496...105,287,405
|
|
G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GCHFR mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:118,998,269...119,002,870
Ensembl chr 2:118,998,254...119,002,871
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions decreases response to substance increases expression decreases expression |
ISO EXP |
[Linoleic Acids, Conjugated results in increased activity of GCLC protein] which results in decreased susceptibility to tert-Butylhydroperoxide GCLC protein results in decreased susceptibility to tert-Butylhydroperoxide [Apigenin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Luteolin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GCLC mRNA tert-Butylhydroperoxide results in decreased expression of GCLC mRNA |
CTD |
PMID:12425961 PMID:17092368 PMID:22864849 PMID:23410634 PMID:27509014 PMID:30547568 More...
|
|
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
|
|
G |
Gclm |
glutamate-cysteine ligase, modifier subunit |
multiple interactions increases expression |
ISO EXP |
[Apigenin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GCLM mRNA |
CTD |
PMID:12414654 PMID:22864849 PMID:23410634 PMID:27509014 PMID:30547568 |
|
NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
|
|
G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GCNT1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:17,303,505...17,350,208
Ensembl chr19:17,303,505...17,350,208
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GCNT3 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 9:69,938,777...69,947,172
Ensembl chr 9:69,938,778...69,945,370
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GDF15 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106
|
|
G |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of GDPD5 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 7:99,027,976...99,111,082
Ensembl chr 7:99,030,621...99,111,084
|
|
G |
Gem |
GTP binding protein overexpressed in skeletal muscle |
multiple interactions increases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GEM mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr 4:11,702,379...11,714,993
Ensembl chr 4:11,704,457...11,714,752
|
|
G |
Gemin4 |
gem nuclear organelle associated protein 4 |
multiple interactions decreases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of GEMIN4 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of GEMIN4 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of GEMIN4 mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr11:76,101,397...76,108,398
Ensembl chr11:76,101,397...76,108,490
|
|
G |
Gfap |
glial fibrillary acidic protein |
decreases expression increases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GFAP protein tert-Butylhydroperoxide results in increased expression of GFAP protein |
CTD |
PMID:24394546 |
|
NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GFER mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:24,912,164...24,915,065
Ensembl chr17:24,912,161...24,915,503
|
|
G |
Gfpt2 |
glutamine fructose-6-phosphate transaminase 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GFPT2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:49,684,981...49,729,448
Ensembl chr11:49,685,005...49,729,440
|
|
G |
Gfra1 |
glial cell line derived neurotrophic factor family receptor alpha 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GFRA1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:58,224,013...58,444,387
Ensembl chr19:58,224,036...58,444,341
|
|
G |
Gins2 |
GINS complex subunit 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GINS2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:121,308,005...121,315,814
Ensembl chr 8:121,305,372...121,316,043
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
decreases expression decreases response to substance |
ISO |
tert-Butylhydroperoxide results in decreased expression of GJA1 mRNA; tert-Butylhydroperoxide results in decreased expression of GJA1 protein GJA1 protein results in decreased susceptibility to tert-Butylhydroperoxide |
CTD |
PMID:15336504 PMID:18235030 |
|
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
decreases response to substance |
ISO |
GJB2 protein results in decreased susceptibility to tert-Butylhydroperoxide |
CTD |
PMID:18235030 |
|
NCBI chr14:57,336,059...57,342,159
Ensembl chr14:57,336,057...57,342,159
|
|
G |
Gla |
galactosidase, alpha |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GLA mRNA |
CTD |
PMID:14729362 |
|
NCBI chr X:133,488,912...133,501,707
Ensembl chr X:133,488,898...133,501,874
|
|
G |
Glg1 |
golgi apparatus protein 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GLG1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:111,879,916...111,985,842
Ensembl chr 8:111,881,053...111,985,848
|
|
G |
Glipr1 |
GLI pathogenesis related 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GLIPR1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:111,821,353...111,838,539
Ensembl chr10:111,821,353...111,838,536
|
|
G |
Glod4 |
glyoxalase domain containing 4 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GLOD4 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr11:76,111,221...76,134,525
Ensembl chr11:76,011,813...76,134,551
|
|
G |
Glrx |
glutaredoxin |
multiple interactions increases expression |
ISO |
[GLRX protein co-treated with Glutathione] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein] tert-Butylhydroperoxide results in increased expression of GLRX mRNA |
CTD |
PMID:12414654 PMID:12680778 |
|
NCBI chr13:75,988,004...75,998,270
Ensembl chr13:75,987,987...75,998,273
|
|
G |
Glrx3 |
glutaredoxin 3 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GLRX3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 7:137,039,302...137,071,360
Ensembl chr 7:137,039,343...137,070,323
|
|
G |
Glyr1 |
glyoxylate reductase 1 homolog (Arabidopsis) |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GLYR1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr16:4,831,766...4,867,780
Ensembl chr16:4,831,773...4,867,727
|
|
G |
Gm12258 |
predicted gene 12258 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of PMS2P3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:58,737,971...58,752,783
Ensembl chr11:58,737,984...58,752,782
|
|
G |
Gm20348 |
predicted gene, 20348 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of TP53I3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:4,860,475...4,867,155
Ensembl chr12:4,860,494...4,867,142
|
|
G |
Gm40318 |
predicted gene, 40318 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of S100P mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 5:36,919,848...36,924,763
Ensembl chr 5:36,919,961...36,924,039
|
|
G |
Gmpr2 |
guanosine monophosphate reductase 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GMPR2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr14:55,909,692...55,935,602
Ensembl chr14:55,909,398...55,916,657
|
|
G |
Gna11 |
guanine nucleotide binding protein, alpha 11 |
increases expression decreases expression |
EXP ISO |
tert-Butylhydroperoxide results in increased expression of GNA11 mRNA tert-Butylhydroperoxide results in decreased expression of GNA11 mRNA |
CTD |
PMID:15003993 PMID:15336504 |
|
NCBI chr10:81,364,558...81,380,996
Ensembl chr10:81,364,558...81,381,024
|
|
G |
Gnai1 |
G protein subunit alpha i1 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of GNAI1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 5:18,470,133...18,565,411
Ensembl chr 5:18,470,133...18,565,353
|
|
G |
Gnas |
GNAS complex locus |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GNAS mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 2:174,126,113...174,188,537
Ensembl chr 2:174,126,113...174,188,537
|
|
G |
Gnb5 |
guanine nucleotide binding protein (G protein), beta 5 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GNB5 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 9:75,213,570...75,253,205
Ensembl chr 9:75,213,570...75,253,158
|
|
G |
Gnpnat1 |
glucosamine-phosphate N-acetyltransferase 1 |
decreases expression |
EXP |
tert-Butylhydroperoxide results in decreased expression of GNPNAT1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr14:45,613,897...45,626,972
Ensembl chr14:45,613,791...45,642,370
|
|
G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GNS mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:121,200,995...121,233,159
Ensembl chr10:121,200,995...121,233,154
|
|
G |
Gosr2 |
golgi SNAP receptor complex member 2 |
decreases expression |
EXP |
tert-Butylhydroperoxide results in decreased expression of GOSR2 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr11:103,567,675...103,590,139
Ensembl chr11:103,567,675...103,588,724
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble |
multiple interactions increases activity increases expression |
ISO |
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; caffeic acid inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GOT1 protein] |
CTD |
PMID:15095147 PMID:15212457 PMID:15645217 |
|
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
|
|
G |
Gpat3 |
glycerol-3-phosphate acyltransferase 3 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GPAT3 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 5:100,994,095...101,046,968
Ensembl chr 5:100,993,579...101,046,968
|
|
G |
Gpc1 |
glypican 1 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GPC1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 1:92,759,367...92,787,933
Ensembl chr 1:92,759,367...92,788,501
|
|
G |
Gper1 |
G protein-coupled estrogen receptor 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GPER1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:139,408,905...139,413,555
Ensembl chr 5:139,408,906...139,413,555
|
|
G |
Gpi1 |
glucose-6-phosphate isomerase 1 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GPI1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 7:33,900,752...33,929,761
Ensembl chr 7:33,900,755...33,929,761
|
|
G |
Gpnmb |
glycoprotein (transmembrane) nmb |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GPNMB mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:49,013,449...49,044,413
Ensembl chr 6:49,013,480...49,047,863
|
|
G |
Gpr107 |
G protein-coupled receptor 107 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GPR107 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:31,042,099...31,106,579
Ensembl chr 2:31,042,328...31,108,787
|
|
G |
Gpr161 |
G protein-coupled receptor 161 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GPR161 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:165,108,760...165,154,314
Ensembl chr 1:165,123,358...165,154,314
|
|
G |
Gpr4 |
G protein-coupled receptor 4 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GPR4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 7:18,946,463...18,958,101
Ensembl chr 7:18,946,463...18,958,099
|
|
G |
Gprc5b |
G protein-coupled receptor, family C, group 5, member B |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GPRC5B mRNA |
CTD |
PMID:15336504 PMID:29432895 |
|
NCBI chr 7:118,571,263...118,594,434
Ensembl chr 7:118,571,270...118,594,434
|
|
G |
Gpsm2 |
G-protein signalling modulator 2 (AGS3-like, C. elegans) |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GPSM2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 3:108,585,954...108,629,637
Ensembl chr 3:108,585,954...108,629,625
|
|
G |
Gpsm3 |
G-protein signalling modulator 3 (AGS3-like, C. elegans) |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GPSM3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:34,808,780...34,810,728
Ensembl chr17:34,808,780...34,810,728
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions increases activity increases expression |
ISO EXP |
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; caffeic acid inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GPT protein] rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein] |
CTD |
PMID:15015760 PMID:15095147 PMID:15212457 PMID:15645217 PMID:28025122 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases reduction decreases response to substance increases response to substance increases expression |
ISO EXP |
GPX1 protein results in increased reduction of tert-Butylhydroperoxide GPX1 protein results in decreased susceptibility to tert-Butylhydroperoxide GPX1 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GPX1 mRNA |
CTD |
PMID:8428933 PMID:9741587 PMID:15182862 PMID:19720132 |
|
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases reduction decreases expression increases expression |
ISO |
GPX2 protein results in increased reduction of tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of GPX2 mRNA tert-Butylhydroperoxide results in increased expression of GPX2 mRNA |
CTD |
PMID:8428933 PMID:10806356 PMID:12414654 PMID:12419474 |
|
NCBI chr12:76,839,109...76,842,328
Ensembl chr12:76,839,107...76,842,273
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions decreases response to substance increases response to substance |
ISO EXP |
GPX4 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] GPX4 protein results in decreased susceptibility to tert-Butylhydroperoxide GPX4 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide |
CTD |
PMID:12566075 PMID:15496407 |
|
NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GRB2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:115,534,871...115,599,423
Ensembl chr11:115,534,871...115,599,423
|
|
G |
Grem1 |
gremlin 1, DAN family BMP antagonist |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GREM1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:113,579,020...113,588,993
Ensembl chr 2:113,576,509...113,588,991
|
|
G |
Grhpr |
glyoxylate reductase/hydroxypyruvate reductase |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GRHPR mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 4:44,981,394...44,990,734
Ensembl chr 4:44,981,395...44,990,734
|
|
G |
Grin2c |
glutamate receptor, ionotropic, NMDA2C (epsilon 3) |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GRIN2C mRNA |
CTD |
PMID:12414654 |
|
NCBI chr11:115,139,995...115,158,123
Ensembl chr11:115,139,995...115,158,069
|
|
G |
Grpel1 |
GrpE-like 1, mitochondrial |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GRPEL1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:36,622,529...36,631,421
Ensembl chr 5:36,622,342...36,631,424
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases expression multiple interactions decreases phosphorylation |
ISO |
tert-Butylhydroperoxide results in increased expression of GSK3B mRNA 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of GSK3B protein] |
CTD |
PMID:15336504 PMID:29128606 |
|
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
|
|
G |
Gsn |
gelsolin |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GSN mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
|
|
G |
Gspt1 |
G1 to S phase transition 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of GSPT1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr16:11,034,104...11,072,189
Ensembl chr16:11,037,156...11,072,189
|
|
G |
Gspt2 |
G1 to S phase transition 2 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GSPT2 mRNA |
CTD |
PMID:14729362 PMID:15003993 |
|
NCBI chr X:93,679,675...93,682,168
Ensembl chr X:93,679,675...93,686,850
|
|
G |
Gsr |
glutathione reductase |
multiple interactions decreases expression increases activity decreases activity decreases methylation increases expression |
ISO EXP |
Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GSR protein] tert-Butylhydroperoxide results in decreased expression of GSR mRNA Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of GSR protein] tert-Butylhydroperoxide results in decreased methylation of GSR gene tert-Butylhydroperoxide results in increased expression of GSR mRNA |
CTD |
PMID:14729362 PMID:15003993 PMID:15212457 PMID:15336504 PMID:15849717 PMID:16126241 PMID:16928893 PMID:17427263 PMID:23410634 PMID:27509014 More...
|
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Gsta3 |
glutathione S-transferase, alpha 3 |
decreases response to substance increases expression |
EXP |
GSTA2 protein results in decreased susceptibility to tert-Butylhydroperoxide; GSTA3 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GSTA2 mRNA; tert-Butylhydroperoxide results in increased expression of GSTA3 mRNA |
CTD |
PMID:14729362 PMID:15003993 |
|
NCBI chr 1:21,310,837...21,335,885
Ensembl chr 1:21,310,813...21,335,885
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GSTK1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:42,222,869...42,227,375
Ensembl chr 6:42,222,869...42,227,381
|
|
G |
Gstm2 |
glutathione S-transferase, mu 2 |
decreases expression decreases response to substance increases expression |
ISO EXP |
tert-Butylhydroperoxide results in decreased expression of GSTM2 mRNA; tert-Butylhydroperoxide results in decreased expression of GSTM2 protein GSTM2 protein results in decreased susceptibility to tert-Butylhydroperoxide; GSTM5 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GSTM2 mRNA; tert-Butylhydroperoxide results in increased expression of GSTM5 mRNA |
CTD |
PMID:14729362 PMID:15003993 PMID:15336504 PMID:24394546 |
|
NCBI chr 3:107,889,018...107,893,736
Ensembl chr 3:107,889,018...107,893,769
|
|
G |
Gstm4 |
glutathione S-transferase, mu 4 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GSTM4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 3:107,937,887...107,952,495
Ensembl chr 3:107,947,724...107,952,210
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GSTP1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
Gstp2 |
glutathione S-transferase, pi 2 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GSTP2 mRNA |
CTD |
PMID:14729362 |
|
NCBI chr19:4,090,288...4,092,221
Ensembl chr19:4,090,285...4,096,023
|
|
G |
Gstt1 |
glutathione S-transferase, theta 1 |
affects metabolic processing |
EXP |
GSTT1 protein affects the metabolism of tert-Butylhydroperoxide |
CTD |
PMID:9854036 |
|
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
|
|
G |
Gstz1 |
glutathione transferase zeta 1 (maleylacetoacetate isomerase) |
affects metabolic processing |
ISO |
GSTZ1 protein affects the metabolism of tert-Butylhydroperoxide |
CTD |
PMID:9396740 |
|
NCBI chr12:87,192,102...87,211,497
Ensembl chr12:87,193,939...87,211,497
|
|
G |
Gtf2f1 |
general transcription factor IIF, polypeptide 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GTF2F1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:57,310,402...57,318,398
Ensembl chr17:57,310,405...57,318,288
|
|
G |
Gtf2i |
general transcription factor II I |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GTF2I mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:134,266,686...134,346,571
Ensembl chr 5:134,266,688...134,343,614
|
|
G |
Gtf2ird1 |
general transcription factor II I repeat domain-containing 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GTF2IRD1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:134,386,515...134,485,628
Ensembl chr 5:134,386,510...134,485,570
|
|
G |
Gtf3a |
general transcription factor III A |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GTF3A mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:146,885,467...146,892,424
Ensembl chr 5:146,885,467...146,892,424
|
|
G |
Gulp1 |
GULP, engulfment adaptor PTB domain containing 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GULP1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 1:44,590,540...44,835,998
Ensembl chr 1:44,590,671...44,835,998
|
|
G |
Gusb |
glucuronidase, beta |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of GUSB mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:130,011,278...130,031,890
Ensembl chr 5:130,017,852...130,031,890
|
|
G |
Gys1 |
glycogen synthase 1, muscle |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of GYS1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 7:45,084,263...45,106,041
Ensembl chr 7:45,084,268...45,106,043
|
|
G |
H1f10 |
H1.10 linker histone |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of H1-10 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 6:87,957,403...87,958,464
Ensembl chr 6:87,957,403...87,958,619
|
|
G |
H2-Bl |
histocompatibility 2, blastocyst |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of H2-BL mRNA |
CTD |
PMID:15003993 |
|
NCBI chr17:36,391,002...36,395,141
Ensembl chr17:36,391,007...36,395,115
|
|
G |
H2-DMb1 |
histocompatibility 2, class II, locus Mb1 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of H2-DMB1 mRNA |
CTD |
PMID:14729362 PMID:15003993 |
|
NCBI chr17:34,372,165...34,379,203
Ensembl chr17:34,372,046...34,379,204
|
|
G |
H2-M2 |
histocompatibility 2, M region locus 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HLA-B mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
|
|
G |
H2-Pa |
histocompatibility 2, P region alpha locus |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HLA-DPA1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:34,303,587...34,304,826
Ensembl chr17:34,303,575...34,304,797
|
|
G |
H2-T10 |
histocompatibility 2, T region locus 10 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of H2-T10 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr17:36,426,763...36,432,336
Ensembl chr17:36,426,768...36,432,357
|
|
G |
H2-T23 |
histocompatibility 2, T region locus 23 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HLA-E mRNA |
CTD |
PMID:15336504 |
|
NCBI chr17:36,340,869...36,343,593
Ensembl chr17:36,340,665...36,343,747
|
|
G |
H2ax |
H2A.X variant histone |
decreases expression increases phosphorylation |
ISO |
tert-Butylhydroperoxide results in decreased expression of H2AX mRNA tert-Butylhydroperoxide results in increased phosphorylation of H2AX protein |
CTD |
PMID:15336504 PMID:33207735 |
|
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
|
|
G |
H2az2 |
H2A.Z histone variant 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of H2AZ2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:6,377,226...6,394,511
Ensembl chr11:6,377,229...6,394,443
|
|
G |
H2bc12 |
H2B clustered histone 12 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of H2BC12 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr13:22,219,991...22,220,490
Ensembl chr13:22,220,040...22,220,515
|
|
G |
H2bc14 |
H2B clustered histone 14 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of H2BC5 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr13:21,906,214...21,906,696
Ensembl chr13:21,906,214...21,906,737
|
|
G |
H3f4 |
H3.4 histone, cluster member |
decreases expression increases methylation |
ISO |
tert-Butylhydroperoxide results in decreased expression of H3-4 mRNA tert-Butylhydroperoxide results in increased methylation of H3-4 gene |
CTD |
PMID:27509014 |
|
NCBI chr11:58,852,537...58,853,099
Ensembl chr11:58,852,599...58,853,364
|
|
G |
H4c14 |
H4 clustered histone 14 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of H4C3 mRNA |
CTD |
PMID:12414654 PMID:15336504 |
|
NCBI chr 3:96,170,250...96,170,633
Ensembl chr 3:96,168,998...96,170,627
|
|
G |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
increases activity increases expression |
EXP |
tert-Butylhydroperoxide results in increased activity of H6PD protein tert-Butylhydroperoxide results in increased expression of H6PD mRNA |
CTD |
PMID:15003993 PMID:15336504 |
|
NCBI chr 4:150,063,931...150,093,480
Ensembl chr 4:150,063,932...150,093,480
|
|
G |
Hadh |
hydroxyacyl-Coenzyme A dehydrogenase |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HADH mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 3:131,027,068...131,065,750
Ensembl chr 3:131,027,068...131,065,750
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of HAMP mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457
|
|
G |
Has2 |
hyaluronan synthase 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HAS2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr15:56,529,023...56,557,942
Ensembl chr15:56,529,023...56,557,935
|
|
G |
Haus7 |
HAUS augmin-like complex, subunit 7 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HAUS7 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr X:72,480,921...72,502,635
Ensembl chr X:72,480,921...72,502,650
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HBEGF mRNA |
CTD |
PMID:12419474 |
|
NCBI chr18:36,637,980...36,648,858
Ensembl chr18:36,637,980...36,648,858
|
|
G |
Hbp1 |
high mobility group box transcription factor 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HBP1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:31,976,449...32,000,529
Ensembl chr12:31,976,253...32,000,534
|
|
G |
Hc |
hemolytic complement |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of C5 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
|
|
G |
Hdac1 |
histone deacetylase 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HDAC1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 4:129,409,897...129,436,516
Ensembl chr 4:129,409,897...129,436,506
|
|
G |
Hdac11 |
histone deacetylase 11 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of HDAC11 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 6:91,133,652...91,151,674
Ensembl chr 6:91,133,647...91,151,674
|
|
G |
Hdac7 |
histone deacetylase 7 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of HDAC7 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr15:97,690,542...97,742,383
Ensembl chr15:97,690,545...97,742,383
|
|
G |
Heatr1 |
HEAT repeat containing 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HEATR1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr13:12,410,256...12,453,774
Ensembl chr13:12,409,908...12,455,170
|
|
G |
Heg1 |
heart development protein with EGF-like domains 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HEG1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr16:33,504,754...33,591,946
Ensembl chr16:33,504,740...33,591,946
|
|
G |
Heph |
hephaestin |
decreases response to substance decreases expression increases expression |
EXP ISO |
HEPH protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of HEPH mRNA tert-Butylhydroperoxide results in increased expression of HEPH mRNA |
CTD |
PMID:14729362 PMID:15003993 PMID:15336504 |
|
NCBI chr X:95,499,042...95,618,091
Ensembl chr X:95,498,965...95,618,091
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HES1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr16:29,883,259...29,886,614
Ensembl chr16:29,883,202...29,886,614
|
|
G |
Hes6 |
hairy and enhancer of split 6 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of HES6 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 1:91,339,204...91,342,901
Ensembl chr 1:91,339,205...91,341,760
|
|
G |
Hgfac |
hepatocyte growth factor activator |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HGFAC mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:35,198,853...35,205,805
Ensembl chr 5:35,198,853...35,205,805
|
|
G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
multiple interactions |
ISO |
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA; [HIF1A protein results in increased expression of MCL1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA] |
CTD |
PMID:15611089 PMID:35690295 |
|
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
|
|
G |
Hikeshi |
heat shock protein nuclear import factor |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of HIKESHI mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 7:89,567,893...89,590,446
Ensembl chr 7:89,566,737...89,590,412
|
|
G |
Hilpda |
hypoxia inducible lipid droplet associated |
multiple interactions increases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr 6:29,272,487...29,275,448
Ensembl chr 6:29,272,487...29,275,445
|
|
G |
Hivep1 |
human immunodeficiency virus type I enhancer binding protein 1 |
decreases expression |
EXP |
tert-Butylhydroperoxide results in decreased expression of HIVEP1 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr13:42,205,304...42,338,504
Ensembl chr13:42,205,497...42,346,013
|
|
G |
Hk1 |
hexokinase 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HK1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr10:62,104,634...62,215,699
Ensembl chr10:62,104,634...62,215,687
|
|
G |
Hmga1 |
high mobility group AT-hook 1 |
decreases expression increases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HMGA1 mRNA tert-Butylhydroperoxide results in increased expression of HMGA1 mRNA |
CTD |
PMID:12419474 PMID:15336504 |
|
NCBI chr17:27,774,798...27,782,649
Ensembl chr17:27,775,471...27,782,648
|
|
G |
Hmga2 |
high mobility group AT-hook 2 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of HMGA2 mRNA |
CTD |
PMID:14729362 |
|
NCBI chr10:120,197,173...120,312,374
Ensembl chr10:120,197,180...120,312,374
|
|
G |
Hmgb1 |
high mobility group box 1 |
increases expression multiple interactions |
ISO |
tert-Butylhydroperoxide results in increased expression of HMGB1 protein 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein] |
CTD |
PMID:28063877 PMID:29111459 |
|
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HMGCR mRNA |
CTD |
PMID:12414654 |
|
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
|
|
G |
Hmgn5 |
high-mobility group nucleosome binding domain 5 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of HMGN5 mRNA |
CTD |
PMID:14729362 PMID:15003993 |
|
NCBI chr X:108,048,143...108,056,986
Ensembl chr X:108,048,140...108,057,010
|
|
G |
Hmox1 |
heme oxygenase 1 |
decreases response to substance multiple interactions increases expression affects expression decreases expression |
ISO EXP |
HMOX1 protein results in decreased susceptibility to tert-Butylhydroperoxide [Apigenin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [chrysin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Luteolin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA] tert-Butylhydroperoxide affects the expression of HMOX1 mRNA [Biological Products results in increased expression of HMOX1 protein] inhibits the reaction [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species]; [Biological Products results in increased expression of HMOX1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; sodium boranocarbonate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 mRNA] tert-Butylhydroperoxide results in decreased expression of HMOX1 mRNA; tert-Butylhydroperoxide results in decreased expression of HMOX1 protein tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA; tert-Butylhydroperoxide results in increased expression of HMOX1 protein 6,7-dihydroxyflavone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein] |
CTD |
PMID:12414654 PMID:15336504 PMID:15589375 PMID:16636651 PMID:17295091 PMID:18812229 PMID:22864849 PMID:22954530 PMID:23266269 PMID:27050144 PMID:27509014 PMID:28025122 PMID:30273691 PMID:30547568 PMID:35077135 PMID:38053484 PMID:38272317 More...
|
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hmox2 |
heme oxygenase 2 |
decreases response to substance decreases expression increases methylation |
ISO |
HMOX2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of HMOX2 mRNA tert-Butylhydroperoxide results in increased methylation of HMOX2 gene |
CTD |
PMID:15589375 PMID:27509014 |
|
NCBI chr16:4,544,225...4,584,606
Ensembl chr16:4,544,225...4,584,606
|
|
G |
Hnrnpa3 |
heterogeneous nuclear ribonucleoprotein A3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HNRNPA3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 2:75,489,416...75,499,751
Ensembl chr 2:75,489,605...75,499,751
|
|
G |
Hnrnpdl |
heterogeneous nuclear ribonucleoprotein D-like |
multiple interactions decreases expression increases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HNRNPDL mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HNRNPDL mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of HNRNPDL mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA] tert-Butylhydroperoxide results in decreased expression of HNRNPDL mRNA |
CTD |
PMID:15336504 PMID:20847119 |
|
NCBI chr 5:100,181,436...100,187,769
Ensembl chr 5:100,181,436...100,187,523
|
|
G |
Hook2 |
hook microtubule tethering protein 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HOOK2 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:85,715,402...85,729,981
Ensembl chr 8:85,717,232...85,729,978
|
|
G |
Hoxd1 |
homeobox D1 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of HOXD1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 2:74,593,324...74,595,486
Ensembl chr 2:74,593,324...74,595,486
|
|
G |
Hp1bp3 |
heterochromatin protein 1, binding protein 3 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HP1BP3 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 4:137,943,781...137,971,994
Ensembl chr 4:137,943,607...137,971,994
|
|
G |
Hps1 |
HPS1, biogenesis of lysosomal organelles complex 3 subunit 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HPS1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr19:42,743,629...42,770,013
Ensembl chr19:42,743,544...42,768,417
|
|
G |
Hs3st3a1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HS3ST3A1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:64,326,158...64,413,667
Ensembl chr11:64,326,158...64,413,667
|
|
G |
Hsbp1 |
heat shock factor binding protein 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HSBP1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 8:120,071,277...120,075,668
Ensembl chr 8:120,071,227...120,075,661
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
decreases expression multiple interactions |
ISO |
tert-Butylhydroperoxide results in decreased expression of HSD11B1 mRNA Catechin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HSD11B1 mRNA]; Grape Seed Extract inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HSD11B1 mRNA] |
CTD |
PMID:29935159 |
|
NCBI chr 1:192,903,917...192,946,345
Ensembl chr 1:192,903,942...192,946,383
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
affects expression |
ISO |
tert-Butylhydroperoxide affects the expression of HSD11B2 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of HSD17B10 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr X:150,784,892...150,787,438
Ensembl chr X:150,784,841...150,787,438
|
|
G |
Hsd17b11 |
hydroxysteroid (17-beta) dehydrogenase 11 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HSD17B11 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:104,137,631...104,169,662
Ensembl chr 5:104,137,628...104,169,785
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of HSD17B2 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 8:118,427,752...118,485,767
Ensembl chr 8:118,428,643...118,485,766
|
|
G |
Hsd3b7 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of HSD3B7 mRNA |
CTD |
PMID:15003993 |
|
NCBI chr 7:127,399,830...127,402,973
Ensembl chr 7:127,399,776...127,402,974
|
|
G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HSP90AA1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr12:110,657,470...110,662,829
Ensembl chr12:110,657,039...110,669,162
|
|
G |
Hspa13 |
heat shock protein 70 family, member 13 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HSPA13 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr16:75,552,078...75,564,575
Ensembl chr16:75,542,319...75,563,992
|
|
G |
Hspa1a |
heat shock protein 1A |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HSPA1A mRNA |
CTD |
PMID:12414654 |
|
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
|
|
G |
Hspa1b |
heat shock protein 1B |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HSPA1B mRNA |
CTD |
PMID:12414654 |
|
NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
|
|
G |
Hspa1l |
heat shock protein 1-like |
multiple interactions increases expression |
ISO |
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA] |
CTD |
PMID:20847119 |
|
NCBI chr17:35,191,679...35,198,204
Ensembl chr17:35,191,679...35,198,261
|
|
G |
Hspa2 |
heat shock protein 2 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HSPA2 mRNA |
CTD |
PMID:12419474 PMID:15336504 |
|
NCBI chr12:76,450,688...76,453,712
Ensembl chr12:76,450,950...76,453,712
|
|
G |
Hspa4 |
heat shock protein 4 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HSPA4 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr11:53,150,641...53,191,306
Ensembl chr11:53,150,641...53,191,284
|
|
G |
Hspa5 |
heat shock protein 5 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HSPA5 mRNA |
CTD |
PMID:12766906 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Hspb1 |
heat shock protein 1 |
increases expression decreases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HSPB1 protein tert-Butylhydroperoxide results in decreased expression of HSPB1 mRNA |
CTD |
PMID:11295360 PMID:15336504 |
|
NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
|
|
G |
Hspb2 |
heat shock protein 2 |
decreases expression increases expression |
ISO EXP |
tert-Butylhydroperoxide results in decreased expression of HSPB2 mRNA tert-Butylhydroperoxide results in increased expression of HSPB2 mRNA |
CTD |
PMID:14729362 PMID:15003993 PMID:15336504 |
|
NCBI chr 9:50,662,372...50,663,654
Ensembl chr 9:50,662,378...50,663,654
|
|
G |
Hspb8 |
heat shock protein 8 |
increases expression |
EXP |
tert-Butylhydroperoxide results in increased expression of HSPB8 mRNA |
CTD |
PMID:14729362 |
|
NCBI chr 5:116,546,550...116,560,923
Ensembl chr 5:116,546,550...116,560,923
|
|
G |
Hspd1 |
heat shock protein 1 (chaperonin) |
increases expression multiple interactions |
ISO |
tert-Butylhydroperoxide results in increased expression of HSPD1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA] |
CTD |
PMID:15336504 PMID:35690295 |
|
NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
|
|
G |
Hsph1 |
heat shock 105kDa/110kDa protein 1 |
decreases expression |
ISO |
tert-Butylhydroperoxide results in decreased expression of HSPH1 mRNA |
CTD |
PMID:15336504 |
|
NCBI chr 5:149,540,308...149,562,594
Ensembl chr 5:149,537,752...149,559,841
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
ISO |
tert-Butylhydroperoxide results in increased expression of HTATIP2 mRNA |
| |